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ABSTRACT
Simulation or statistically based models are often used to explore the outcomes and dynam-
ics of physical systems or scientific experiments. In this work, we consider the use of a mixed
effects differential equations model and the use of a stochastic agent based model to model data
from competition infection experiments of Equine Infectious Anemia Virus (EIAV). EIAV is a
retrovirus that presents with a lifelong persistent infection. Vaccine development for this and
other retroviruses has been impeded due to the genetic variation that the virus exhibits in the
presence of host immune pressure. To assess if genetic variation has an impact on replicative
capacity, variants of EIAV that differ phenotypically were competed in dual infection assays.
Data from these experiments were used to develop models that are aimed at being able to
detect if there are differences in replicative capacity among the variants.
We first consider a mixed effects model of data from an in vivo competition assay. Pa-
rameters of the model are estimated through the use of Markov Chain Monte Carlo (MCMC)
methods. In vitro competition experiments were also conducted. These experiments offer more
controlled experimental conditions than the in vivo assays. We then propose an agent based
computer model that is able to simulate cell free and cell associated virus spread to model
the data from the in vitro competition assays. To estimate the parameters of the agent based
model, a surrogate Gaussian process model is used. Finally, we propose an extension of the
Gaussian process model to account for the additional variance present in stochastic computer
models.
1CHAPTER 1. INTRODUCTION
1.1 Thesis Organization
This thesis is concerned with the statistical analysis of viral infection assays. All models
are constructed from infection assays designed to detect fitness differences among different
variants of Equine Infectious Anemia Virus. Chapter 1 is an introductory chapter that discusses
foundational ideas behind computer modeling and virus infection. Chapter 2 details a statistical
model of an in vivo competition experiment of EIAV. A nonlinear mixed effects model was
considered to model the virus growth of infected foals. Markov Chain Monte Carlo (MCMC)
methods were used to estimate the posterior distribution of the parameters in the model.
Results indicated that there was a significant fitness difference among the two variants in the
in vivo experiments. The in vivo competition assays were conducted by Robert H. Mealey
at Washington State University. In Chapter 3, a stochastic agent based model of in vitro
EIAV competition experiments is developed. The in vitro competition experiments competed
the same variants as those in the in vivo experiments, however, in this case the experiments
are more controlled. The in vitro competition assays were conducted by Wuwei Wu in the
laboratory of Susan Carpenter. The input parameters of the agent based model represent virus
and cell characteristics that could inform on any fitness differences among the variants. Markov
Chain Monte Carlo methods were used to calibrate the agent based model to the experimental
data. Results showed that there was not a significant fitness difference among the variants in
vitro. Chapter 4 describes a Gaussian process predictive distribution for emulating the output
of a stochastic computer model. When calibrating computer models to actual experimental
data, it is often useful to use a statistical approximation to the computer model. Polynomial
regression models are proposed to model the stochastic variance in the output of the computer
2model. Chapter 5 summarizes the findings of this thesis and discusses topics of future work.
References are located at the end.
1.2 Computer Modeling
Statistical and mathematical models have been commonly used to model scientific and phys-
ical experiments. Differential equation models have been used to model population dynamics
and infection of HIV (Wu et al. (2006); Schwartz et al. (2005)), stochastic differential equation
models have been proposed to model individuals in pharmokinetic models (Mortensen et al.
(2007)), and many applications of computer based models have been proposed to model exper-
iments ranging from chemical reactions (Gillespie (1977)) to systems biology (Henderson et al.
(2009)). These models provide a way to quantify reactions and phenomena within the exper-
iments they model. In the case of differential equation models, a set of equations are used to
describe the rates of change of states in the experiment being modeled. An appeal of this type
of modeling is that the system of equations can be simple and can follow the intuition of the
experimenters. This provides a pleasant platform for model specification. Computer models,
also referred to as computer experiments, are codes used to coincide with and explain natural
phenomena or actual physical experiments. They can simulate complex, emergent behavior
by allowing the user to focus on understanding low level phenomena, which is typically the
beginning of deduction in science. Computer models can be designed to model a wide variety
of applications. All of these models are tools to describe simple or complex processes. They
also provide a way to measure the reactions and dynamics involved in these processes. These
models can become very useful if they are fit to data and can produce observations congruent
to what would happen in reality.
1.2.1 Computer Models
The term computer model is broad, as there are many types of computer generated models
that fall under this category. Deterministic computer models produce the exact same output
for a given input. Stochastic models rely on randomization in the specification of how events
are carried out in the model. Given this randomization, for a given input, the output generated
3can be different each time the model is executed. Many computer models simulate events as
they occur in time. How time is handled can be a distinguishing factor in computer models as
time in a model can be either continuous or discrete. Dancik et al. (2010) proposed an Agent
Based Model of Leishmania major infection in which events occurred according to discrete
time steps that were approximately 6 seconds of real time. Gillespie (1977) modeled coupled
chemical reactions with stochastic models that simulated continuous time by sampling elapsed
time from exponential distributions. Henderson et al. (2009) use a continuous time discrete
state space Markov model to describe the relationship between deletions of mitochondrial DNA
and neuronal loss in the human brain of patients with Parkinson’s disease.
1.3 Equine Infectious Anemia Virus
Equine infections anemia virus (EIAV) is a retrovirus that induces a persistent infection in
the equines it infects. Retroviruses are RNA viruses that use the enzyme reverse transcriptase
to produce DNA from RNA. This virus is well characterized and is used as an animal model for
the Human Immunodeficiency Virus (HIV). Understanding how EIAV evades the host immune
response could lead to better understanding of HIV in humans.
1.3.1 Transmission and Disease
Equine Infectious Anemia Virus infects equids world wide. EIAV is characterized by a
variable febrile disease course that can include an acute, chronic, inapparent, and recrudescent
stage, Figure 1.1. The main mode of infection is by insects carrying the virus, namely the
horsefly with the virus on its mouthparts (Leroux et al. (2004)). Equids can also be infected by
exposure to infected bodily fluids or from infected needles. The virus causes fever, thrombocy-
topenia, and wasting in infected equids (Leroux et al. (2004)). Thrombocytopenia is decreased
platelet counts in the blood. EIAV causes a lifelong infection. Even when an infected equid is
in the inapparent stage of infection when there are no clinical symptoms it is still infectious.
Infected equids are either euthanized or quarantined (Leroux et al. (2004)). This practice as
well as testing of animals presents a way to control the spread of infection.
41.3.2 Antigenic Variation
EIAV is an enveloped virus, meaning it has a lipid membrane surrounding it’s viral RNA.
The V3 region of the surface protein is a variable region known as the Principle Neutralizing
Domain (PND). It is hypothesized that variation here during disease progression can contribute
to host immune evasion. Viral receptors on the envelope of the virus recognize and bind
to receptors on susceptible cells. The virus then enters the cell through receptor mediated
endocytosis (Jin et al. (2005)). Neutralizing antibodies produced by the host immune system
may also learn to bind to these viral receptors. Variation in the surface protein of the virus
may enable the virus to evade detection by neutralizing antibodies, but variation may also
impact the virus’ ability to bind to cell receptors of susceptible cells. The virus neutralization
plot in Figure 1.2 shows the neutralization curves of five variants of EIAV. Virus neutralization
by antibodies is the abrogation of virus infectivity by the binding of antibodies to the virus
(Klasse and Sattentau (2002)). Focus forming units (FFU) are the number of units capable
of forming a cluster of infected cells. The curves in the plot depict the highest serum dilution
that gave a 75% reduction in FFU as compared with pre-inoculation and negative control
serum. These five variants differ in the PND and all arose at different times in vivo. Sera
collected from foals before 118 days post infection were only effective at neutralizing EIAV
variant PND1. Sera collected later were able, to some degree, neutralize the other variants.
A broadly neutralizing antibody response which evolves later, is able to recognize and bind
multiple variants. Variant PND5 was the last variant to arise in vivo and appears to be the
most resistant to neutralization. This resistance may also coincide with a decreased infectivity.
Support for this hypothesis is offered by the observation that PND5 is not prevalent early in the
infection when immune presses are minimal, in other words, PND5 appears unable to compete
with PND1 before there is a vigorous immune response. Competition infection assays were
developed to confirm the hypothesized differences in viral fitness among variants PND1 and
PND5.
5Figure 1.1 Disease course of pony infected with EIAV (Sponseller et al. (2007)).
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Figure 1.2 Virus Neutralization Plot: Circles indicate when a particular variant was detected
in vivo. Color bars coincide with the febrile cycle during the course of the infec-
tion. Curves in the plot indicate the neutralization of each PND variant by serum
collected after inoculation of virus (Sponseller et al. (2012)).
61.3.3 Competition Experiments
The continuous evolution of viruses contribute to their ability to escape and evade host
immune control. Experiments were conducted with the goal of determining if changes in the
host immune environment during the progression of the disease contribute to the presence of
escape variants that have an altered replicative fitness. In vivo competition experiments can
be used to determine if there is a detectable difference in replicative fitness among the variants.
Replicative fitness refers to the ability of a virus to make more of itself. Severe Combined
Immunodeficiency Disease (SCID) is a genetic disorder that is characterized by a defective
adaptive immune system. SCID foals will eventually die from some opportunistic infection. In
the assays, SCID foals were infected with EIAV variants PND1 and PND5 and virus copy per
ml of blood was measured. In a SCID foal, the two EIAV variants compete without interference
from host immune cells. In vitro competition experiments were conducted to determine if there
was a fitness difference between the two variants. The in vitro competition assays offer a more
controlled experiment as compared to the in vivo assays. In these assays, susceptible cells were
coinfected with both PND1 and PND5 variants. Virus copy number and provirus copy number
were measured for both variants.
7CHAPTER 2. MODELING IN VIVO COMPETITION INFECTION
ASSAYS WITH A BAYESIAN NON LINEAR DIFFERENTIAL
EQUATION MIXED EFFECTS MODEL
Equine infectious anemia (EIA) is a horse disease caused by the EIA virus. The EIA virus is
a retrovirus with similarities to the Human Immunodeficiency Virus (HIV). EIAV is being used
as an animal model to investigate virus factors that are important in the evolution and selection
of immune escape variants during the course of infection. EIAV is an enveloped virus causing a
persistent lifelong infection that has a distinct variable disease course that can include an acute,
chronic, inapparent, and recrudescent stage of clinical symptoms (Wu et al. (2011)). The EIAV
surface protein is located in the envelope and plays an important role in the virus’ life cycle.
It contributes to infection of host cells by binding to receptors on the cell membrane, and it
interacts with the host’s immune system, especially antibodies. The persistence of the EIAV
infection in vivo is a function of its ability to evade the host immune system and replicate. The
purpose of the proposed studies is to determine if genetic changes that arise in the presence of
immune pressure contribute to decreased replicative capacity.
Experiments have been designed to compete two EIAV variants in vivo. In the assays, foals
were coinfected with the two variants. The two variants differ only in the principle neutralizing
domain and are labeled PND1 and PND5. The principle neutralizing domain (PND) is a
variable region of the EIAV surface protein that contains epitopes, short polypeptides, that are
recognized by neutralizing antibodies. Neutralizing antibodies can recognize and bind to viruses
making them incapable of infecting cells. Broadly neutralizing antibodies are antibodies that
are capable of inhibiting the function of many variants of a virus species. Sponseller et al. (2007)
conducted a study of the surface protein of EIAV in foal experimentally inoculated with EIAV.
Serum sampled form the foal revealed distinct variants that differed in the PND region. Among
8these variants were PND1 and PND5. Variant PND5 was more resistant to neutralization by
broadly neutralizing antibodies as compared to PND1 and showed decreased infectivity in
vitro. Genetic variation in the PND is considered to play an instrumental role in aiding host
immune evasion and virus persistence (Wu et al. (2011)), but it is hypothesized that virus with
resistance to broadly neutralizing antibodies could incur some cost in replicative capacity. The
experiments were designed to test for fitness differences between PND1 and PND5.
We propose to model the assays using a system of nonlinear differential equations. Differ-
ential equation models have been commonly used to describe the dynamics of viral infection
systems (Schwartz et al. (2005); Wu et al. (2006)). The equations describe the rate of change of
both observable and non observable states in the assay. The parameters in the system of equa-
tions give insight to properties of the virus that are of interest, such as the rates of infection for
both of the virus variants. The assays include replicate measurements from multiple individuals
(foals). The inclusion of data from multiple individuals introduces additional variation that is
separate from measurement error providing a natural framework for mixed effect modeling.
2.1 Methods
2.1.1 In vivo EIAV infection assays
Two SCID foals were injected with 2 ml aliquots containing equal numbers of focus forming
units (FFU) of each variant. Severe combined immunodeficiency, SCID, is a genetic disorder
in which the adaptive immune system is not functional. Samples were taken from the SCID
foals at 5, 7, 10, 14, 18, and 21 days. One SCID foal had an additional sample taken at day
25. The virus copy numbers per ml of blood was measured in duplicate for each virus at each
sampled time. Figures 2.1(a) and 2.1(b) show the data from the two SCID foals.
2.1.2 Ordinary Differential Equation Model
The differential equation model fitted to the experimental data from the competition assays
provides a way to estimate parameters describing the behavior of the viruses. The following
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Figure 2.1 In vivo competition assay: Log10 virus copy/ml of blood as a function of days post
infection. Lines connect the mean within replicate measurements at each sampled
time. For SCID Foal 2295 at DPI 20, there was only 1 replicate measurement of
PND5.
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system of nonlinear differential equations (2.1) describes the dynamics of virus within each foal
dC
dt
= λ− ρC − β1CV1 − β2CV5
dF1
dt
= β1CV1 − δF1
dF2
dt
= β2CV5 − δF2 (2.1)
dV1
dt
= bF1 − γV1
dV5
dt
= bF2 − γV5
where states x = (C,F1, F2, V1, V5) represent target cells, PND1 infected cells, PND5 infected
cells, PND1 virus, and PND5 virus respectively. Model parameters φ = (λ, ρ, β1, β2, δ, b, γ)
correspond to the rates of target cell production, target cell death, infection by virus PND1,
infection by virus PND5, infected cell death, virus production, and virus clearance. Assess-
ing differences in replicative fitness is the main focus of these competition infection assays.
Parameters β1 and β2 are directly related to the replicative fitness of each PND variant.
This model specifies that the amount of uninfected cells increases at a constant rate λ and
that cells live on average 1/ρ days and die. Uninfected cells are also lost due to infection at
rates proportional to the amount of virus present and the virus infection rates, β1 and β2. Both
viruses are assumed to be equally pathogenic, killing infected cells at rate δ. The model also
assumes that the rate of virus production, b, and virus clearance rate, γ are equal for both
infected cell types.
The dynamics of cell free virus are faster than that of infected cells, implying that the
state of cell free virus is in a quasi-steady state with respect to the infected cell dynamics,
i.e. dVi/dt = 0, for i = 1, 5 (Wu et al. (2006)). Thus, the amount of free virus is directly
proportional to the amount of infected cells: V1 = kF1 and V5 = kF2, reducing the system of
differential equations to
dC
dt
= λ− ρC − β1CV1 − β2CV2
dV1
dt
= kβ1CV1 − δV1 (2.2)
dV2
dt
= kβ2CV2 − δV2
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where k = b/γ is a constant of proportionality. Use of this system requires estimation of fewer
parameters and involves only one latent (unobservable) state C(t).
Specification of some parameters was done heuristically through calculations using known
information about host cell and virus interactions. The monocyte count in SCID foals and
the turnover rate of macrophages provides a way to calculate the initial amount of susceptible
cells, C(0) = C0. Monocytes are white blood cells capable of differentiating into macrophages
and dendritic cells which are the cells that EIAV infects. Mealey et al. (2008) have measured
monocyte count in the peripheral blood of 4 SCID foals. The average monocyte count among
these four foals was about 350 cells/µl. We model the monocyte population such that the
amount of monocytes increase at a constant rate λ. Monocytes are loss by differentiation into
susceptible macrophages and dendritic cells at a rate proportional to their population such that
dM
dt
= λ− dM (2.3)
where M is the state variable for monocytes and d is the conversion rate for differentiation into
macrophages and dendritic cells. Before the initial infection, susceptible cells change at a rate
dC
dt
= dM − ρC. (2.4)
Fidalgo-Carvalho et al. (2009) report that the approximate life span of the macrophage-like cell,
EML-3C, a differentiated equine monocyte derived macrophages (eMDM), to be 12 days. Thus,
the death rate of susceptible cells, ρ, is specified to be 112 = 0.083 cells/day. Hasegawa et al.
(2009) calculated the monocyte turnover rate of the monocyte cells of six rhesus macaques.
The estimated turnover rate was d = 0.1255 cells/day. Assuming equilibrium, dMdt =
dC
dt = 0
and dM = ρC0 which implies that the initial number of susceptible cells is C0 = dM/ρ.
Assuming these observations are applicable, the number of susceptible cells initially is C0 =
527100 cells/ml. Further, λ = dM , it follows that λ = 0.1255× log10(350000) = 0.696.
2.1.2.1 Model Identifiability
Models similar to the system of equations proposed in (2.2) have been used to model
the dynamics of HIV infection (Wu et al. (2006); Perelson et al. (1996)). If the parameters,
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φ, of the nonlinear system of differential equations dx/dt = f(x(t),φ) are identifiable, then
f(x(t),φA) = f(x(t),φB) if and only if φA = φB. Identifiability can be assessed by directly
testing the dynamic system using the definition of identifiability (Miao et al. (2011)). The
equality f(x(t),φA) = f(x(t),φB) for the system of equations in (2.2) gives
λA − ρAC − β1ACV1 − β2ACV2 = λB − ρBC − β1BCV1 − β2BCV2
β1AkACV1 − δAC = β1BkBCV1 − δBV1 (2.5)
β2AkACV2 − δAV2 = β2BkBCV2 − δBV2
It follows that λA = λB, ρA = ρB, β1A = β1B β2A = β2B, kA = kB, and δA = δB which
indicates that all parameters are identifiable. Identifiability here is contingent upon the initial
values of the latent (unobservable) state, C0, being known, which is the case in this model. If
state variables are not measured they need to be known or otherwise eliminated to use this
approach for assessing identifiably (Miao et al. (2011)).
2.1.3 Nonlinear Mixed Effects Model
We fit the data using a nonlinear mixed effects model that allowed random horse effects.
This model assumes that responses from foals come from a similar model but each foal has
parameters that are allowed to vary. A Bayesian approach is used to fit the model.
2.1.3.1 Model
Let Y it = (yi1t, yi2t)
′ be the mean, across replicate measurements, observed log10 copies of
PND1 and PND5 per ml of blood respectively for SCID foal i at sampled time t. We model
this response to be jointly independent such that
Yit | θi, σ2, V0 ∼ N2

 V1,it(θi)
V5,it(θi)
 ,
 σ2 0
0 σ2

 (2.6)
where σ2 is the measurement error and V1,it(θi) and V5,it(θi) are the numerical solutions for
states V1 and V5 at time t in Equations (2.2) with parameter vector θi = (ki, log βi1, αi, log δi)
where i indexes the individual SCID foals. Parameter log βi2 is modeled as αi log βi1. Here, V0
is the initial log10 virus copies/ml of blood for both PND1 and PND5.
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Between Individual Variation The between foal variation is modeled through the use
of random effects in the mixed effects model. We assume that there is a true set of parameters
µ = (k, log β1, α, log δ) that determines the dynamics of the virus-cell interactions for an average
foal in vivo. However, due to natural variability, individual foals may have parameters and
consequently dynamics that vary from this true set of governing parameters. We model this
deviation from the true parameters in the following way
θi ∼ N4(µ,Σ) (2.7)
where Σ is the covariance matrix describing the variation of the parameters. We assume the
parameters are independent and model Σ as a diagonal matrix, Σ = diag(τ1, τ2, τ3, τ4).
2.1.3.2 Bayesian Model
Bayesian modeling of this nonlinear mixed effects model can be framed in the form of
a hierarchical model consisting of a data model, a random parameter model, and a model
representing prior knowledge of the parameters. The likelihood or joint data model can be
considered as the product of univariate Normal distributions,
f(Y 1,Y 2, | θ1,θ2, σ2, V0) =
2∏
i=1
Ti∏
t=1
1
2piσ2
exp
{
− 1
2σ2
[
(Y1,it − V1,it(θi))2 + (Y5,it − V5,it(θi))2
]}
.
(2.8)
Here, Ti is the total number of time points that the i
th foal was sampled. The joint random
parameter model is modeled as a product of multivariate Normal distributions,
g(θ1,θ2 | µ,Σ) =
2∏
i=1
1
(2pi)2
| Σ |−1/2 exp
{
−1
2
(θi − µ)TΣ−1(θi − µ)
}
. (2.9)
The prior information model represents the prior knowledge for the parameters in the data
and random parameter models. The sample variation, σ2, in the virus copy number at each
sampled time provides information on the amount of measurement error involved in measuring
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virus copy number.
pi
(
σ−2
)
=
bα
Γ(a)
(
σ−2
)a−1
exp
{−bσ−2} (2.10)
pi(µ) =
1
(2pi)4/2
| Ω |−1/2 exp
{
−1
2
(µ− µ0)TΩ−1(µ− µ0)
}
(2.11)
pi(τj) ∝
(
1 +
(τj
A
)2)−1
. (2.12)
We assume the prior knowledge of 1/σ2 is captured with a Gamma distribution with shape
a = 2.932 and rate b = 2.93. Choice of this prior is motivated by using data from previ-
ous experiments in which virus copy number and provirus copy number were measured (Wu
et al. (2011)). Huang and Wu (2006) and Huang et al. (2010) developed dynamic models
to model HIV clinical trial data using differential equations. They used a weakly informa-
tive Multivariate Normal prior with mean µ0 = (2,−10.403, 1,−0.994)′ and variance matrix
Ω = diag(10, 81, 10, 25) for the vector of true parameters µ. The mean infection and infected
cell death rates were estimated using the clinical trial data. The average of the log infection
rates estimated from Huang and Wu (2006) and Huang et al. (2010) was -10.403 with standard
deviation 1.689. Perelson et al. (1996) used ODE models to model in vivo HIV infection data
among five HIV-1 infected patients. The death rate of infected cells was estimated as a part of
the ODE model used. The average log infected cell death rate from the models of Perelson et al.
(1996), Huang and Wu (2006), and Huang et al. (2010) was -0.905 with a standard deviation of
0.166. These average parameter estimates were used as the center of a vague prior for the log
infection rate of PND1 and the log death rate of infected cells. Prior mean for α is 1 assuming
a priori that there is no difference between the two variants. The amount of free virus is greater
than the number of infected cells. Reflecting this, scale constant k should be greater than 1.
Prior specification for k was chosen such that mean is greater than 1 and that the variance
is large enough to still be weakly informative. The variance matrix Ω was chosen such that
marginal variances were large establishing the prior distribution vague enough to allow the data
drive posterior inference. A vague uniform prior over the range 0 to 100 is placed on V0, the
initial log10 virus copies/ml of blood for both PND1 and PND5. In cases where specific prior
knowledge is unavailable, Gelman (2006) suggest a weakly informative half Cauchy distribution
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for prior distributions of group-level variance parameters in hierarchical models as opposed to
non informative uniform distributions when the number of groups, here foals, is small. Usage
of non informative uniform distributions could lead to unrealistically broad posterior distribu-
tions. For each τj a half Cauchy distribution with scale parameter A = 25 is used for the prior
distribution (2.12). Choice of scale parameter should reflect the upper limit of what is believed
to be a reasonable value of the variance parameter.
Given the joint data model, random parameter model, and the prior distribution for the
parameters, the joint posterior distribution is given by Bayes’ theorem as
pi(θ1,θ2, V0,µ,Σ, σ
2 | Y1,Y 2) ∝ f(Y 1,Y 2, | θ1,θ2, σ2)g(θ1,θ2 | µ,Σ)pi(σ−2)pi(µ)pi(τ1)4
(2.13)
which we estimate using Markov Chain Monte Carlo (MCMC). The marginal posterior dis-
tribution for 1/σ2 and µ has a simple form due to choice of conjugate priors. The marginal
posterior for the inverse measurement error, pi(σ−2 | Y 1,Y 2,θ1,θ2, V0), is proportional to a
Gamma distribution with shape parameter, a+ 2(T1 + T2), and rate parameter
b+
∑2
i=1
∑Ti
t=1
[
(Y1,it − V1,it(θi))2 + (Y5,it − V5,it(θi))2
]
2
.
The marginal posterior for µ is Normal with mean
(
Ω−1 + 2Σ−1
)−1 (
Ω−1µo + 2Σ
−1θ¯
)
and
variance
(
Ω−1 + 2Σ−1
)−1
where θ¯ is the mean of θ1 and θ2.
2.1.3.3 Markov Chain Monte Carlo
MCMC is a sampling method that draws samples from a probability distribution up to a
constant of proportionality by sampling long Markov chains (Gilks et al. (1996)). Construction
of the Markov chains can be done using many methods. We use a Metropolis Hastings within
Gibbs sampling algorithm. Gibbs sampling is an algorithm for sampling a subset of param-
eters at a time by sampling from full conditional distributions (Gelfand et al. (1990)). The
Metropolis-Hastings algorithm uses a proposal distribution to generate candidate samples that
are either accepted or rejected. This method can be used within Gibbs sampling to sample
from full conditional distributions that are not simple to sample from directly.
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As a result of conjugate priors, the parameters with simple closed form full conditional
distributions were sampled using Gibbs sampling. The full conditional posterior distributions
of all other posterior parameters was sampled using Metropolis Hastings with a normal proposal
distribution. Let φ(d) be the dth sample from the posterior distribution for a generic parameter
vector φ = (λ, ψ) where λ has a simple closed form distribution and ψ does not. The sampling
algorithm proceeds in the following fashion
1. Choose initial values of parameters φ(0)
2. Given the current realization of φ(d−1), generate ψ∗ from proposal density
ψ∗ ∼ J
(
· | ψ(d−1)
)
3. Calculate metropolis acceptance ratio
(a) r = min
{
1,
f(Y1,Y 2|λ(d−1),ψ∗)pi(λ(d−1),ψ∗)/J(ψ∗|ψ(d−1))
f(Y1,Y 2|φ(d−1))pi(φ(d−1))/J(ψ(d−1)|ψ∗)
}
(b) Set ψ(d) =
 ψ
∗, with prob. r
ψ(d−1), with prob. 1− r
4. Sample λ(d) from full conditional density
λ(d) ∼ pi
(
· | Y1,Y 2, ψ(d)
)
5. Repeat 2-4 until convergence and the desired number of posterior samples are obtained
Convergence to the stationary posterior distribution can be assessed visually as well as
with some statistical measures of convergence. Trace plots can be used as a tool for visual
inspection of convergence. Trace plots are plots of posterior draws at each iteration which
provide a picture of the mixing behavior of the chain. The Gelman-Rubin statistic is a measure
of convergence that uses m ≥ 2 post burn in chains of length N to assess convergence of any
continuous parameter in the MCMC sample (Brooks and Gelman (1998)). Suppose λi are the
MCMC samples of a continuous parameter in the posterior. For m chains {λ1, . . . ,λm} of
length N , the statistic computes the ratio of the stationary distribution variance to the within
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chain variation. The stationary distribution variance is estimated using a weighted average of
the within chain and between chain variation. The within chain variation, W , is
W =
1
m
m∑
j=1
s2j (2.14)
where s2j is the sample variance of the chain λj . The between chain variation, B, is
B =
N
m− 1
m∑
j=1
(
λ¯j − λ¯
)2
(2.15)
where λ¯j is the sample mean from the N samples in chain λj and λ¯ is the mean from the N×m
samples in all m chains. The stationary distribution variance is estimated using the weighted
average σˆ2s ,
σˆ2s =
(
N − 1
N
)
W +
1
N
B. (2.16)
To account for variability in λ¯, Vˆ = σˆ2s + B/(mN) is used as a pooled stationary distribution
variance estimator. The Gelman-Rubin statistic is
R =
Vˆ
W
(
d+ 3
d+ 1
)
(2.17)
The correction factor (d+ 3)/(d+ 1) adjusts for sampling variability in the variance estimates.
The parameter d ≈ 2Vˆ /v̂ar(Vˆ ) is the estimated degrees of freedom for the t-distribution. The
statistic is based on the assumption that the stationary distribution is normal, the use of
the t-distribution accounts for the fact that the true variance of the stationary distribution is
unknown and estimated from samples. Values of the statistics, R, close to 1 suggest that the
chains are close to the stationary distribution.
2.2 Results
Samples from the posterior distribution were obtained by the methods outlined in Sec-
tion 2.1.3.3. Three independent MCMC chains with different starting values of length 1,000,000
were sampled using a burn in period of length 200,000. Convergence was monitored through
the use of trace plots that all seemed to converge. The Gelman-Rubin statistic was com-
puted for each posterior parameter using the R package coda (Plummer et al. (2006)). The
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Gelman-Rubin statistic for each posterior parameter is presented in Table 2.1. Approximate
convergence was met for the posterior parameters as the Gelman-Rubin statistics are all close
to 1. A summary of the marginal posterior distribution for the posterior parameters is given in
Table 2.1. Figures 2.2 - 2.7 show the marginal posterior distributions of the parameters. The
data were informative on the distribution of the measurement error, the initial amount of log
virus, and the proportionality constant between the infection rates of PND1 and PND5.
The marginal posterior densities for most of the parameters appear unimodal with no
extreme skewness. The data were largely informative for the inverse measurement error, 1/σ2,
the initial log10 virus copies/ml, V0, and the constant of proportionality α. From the results
in Figure 2.8, the model seems to reasonably fit the data. Posterior 95% credible sets for both
α1 and α2, Table 2.1, are above 1 indicating a difference in infection rates among the two
PND variants. This follows the results of Wu et al. (2011), as PND1 was observed as being
more infectious than PND5 in single round infectivity assays. These results would suggest that
PND1 is more infectious early in the infection of dual infected SCID foals.
2.3 Discussion
A nonlinear mixed effects model was used to model the data. The nonlinear model relied
on a system of differential equations similar to systems that have been proposed to model HIV
(Huang et al. (2010); Perelson et al. (1996); Wu et al. (2006)). A Bayesian approach was used
to fit the data via MCMC methods. The model was able to effectively model the behavior of
the individual foals by taking into account that the parameters of the model may vary from
foal to foal. Results support the hypothesis that increased resistance to broadly neutralizing
antibodies could incur some cost in replicative capacity.
Assumptions have been made to simplify the model. The model assumes that observations
of two variants are independent even though the foals were coinfected with both variants and
the behavior of one variant may indeed have some effect on the other variant. In the model
we assumed that the initial conditions of both foals are equal. The conclusions may be highly
sensitive to this assumption. For example, much of the later differences in levels of PND1 and
PND5 in Foal 2295 could be explained by different initial amounts of PND1 and PND5 in the
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Figure 2.2 Posterior and Prior for inverse measurement error 1/σ2
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Figure 2.3 Posterior and Prior for initial log10 virus copies/ml of blood
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Figure 2.4 Posterior and Prior Density Estimates for k1 and k2. Prior Density, pi(ki), obtained
by integrating over posteriors for k and τ21
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Figure 2.5 Posterior and Prior Density Estimates for log β11 and log β21. Prior Density,
pi(log βi1), obtained by integrating over posteriors for log β1 and τ
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Figure 2.6 Posterior and Prior Density Estimates for α1 and α2. Prior Density, pi(αi), ob-
tained by integrating over posteriors for α and τ23
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Figure 2.7 Posterior and Prior Density Estimates for log δ1 and log δ2. Prior Density, pi(log δi),
obtained by integrating over posteriors for log δ and τ24
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Figure 2.8 Non linear mixed effects model data fit
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inoculum (Figure 2.1(b)). A random component could be placed onto these variables to allow
foal to foal variation in these conditions. With limited data, additional parameters could lead
to practical estimability issues. The model assumes that the viruses are equally pathogenic,
infected cells have equal production of both viruses, and that both viruses are cleared at equal
rates. These assumptions may need to be further studied, or the sensitivity of the model to
these assumptions may need to be addressed.
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Table 2.1 Posterior mean, standard deviation, and 95% credible set for posterior parameters.
Gelman-Rubin statistic form = 3 chains with stationary distribution Equation 2.13.
Parameter Mean S.D. 95% Credible Set R
σ2 0.296 0.077 ( 0.182 , 0.48 ) 1.00
V (0) 0.612 0.363 ( 0.045 , 1.424 ) 1.01
τ21 0.055 0.283 ( 0.001 , 0.303 ) 1.03
Σ τ22 0.041 0.211 ( 0.002 , 0.2 ) 1.03
τ23 0.02 0.129 ( 0.001 , 0.102 ) 1.00
τ24 0.038 0.187 ( 0.002 , 0.189 ) 1.02
k 2.837 0.615 ( 1.805 , 4.286 ) 1.01
µ log β1 -3.332 0.414 ( -4.114 , -2.491 ) 1.01
α 1.02 0.097 ( 0.83 , 1.211 ) 1.00
log δ -2.921 0.353 ( -3.741 , -2.33 ) 1.03
k1 2.771 0.612 ( 1.78 , 4.235 ) 1.02
Foal 745 log β11 -3.38 0.418 ( -4.155 , -2.505 ) 1.01
θ1 α1 1.014 0.006 ( 1.005 , 1.028 ) 1.01
log δ1 -2.952 0.325 ( -3.727 , -2.421 ) 1.03
k2 2.908 0.598 ( 1.907 , 4.34 ) 1.02
Foal 2295 log β21 -3.279 0.369 ( -3.965 , -2.52 ) 1.01
θ2 α2 1.026 0.008 ( 1.014 , 1.045 ) 1.02
log δ2 -2.89 0.343 ( -3.703 , -2.323 ) 1.04
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CHAPTER 3. AGENT BASED MODEL OF IN VITRO EIAV
INFECTION WITH CELL FREE AND CELL ASSOCIATED VIRUS
SPREAD
3.1 Introduction
Diversity within the Human Immunodeficiency Virus (HIV) coupled with the ability to
evolve under host immune pressure is a major factor inhibiting vaccine development for HIV
(Barouch (2008)). Experiments using the related Equine Infectious Anemia Virus (EIAV) were
conducted to identify factors leading to evolution and selection of immune escape variants
during the progression of the infection. Equine infectious anemia (EIA) is a horse disease
caused by EIAV. The EIA virus is a retrovirus with similarities to HIV (Leroux et al. (2004)).
EIAV is an enveloped virus that induces a chronic infection that has a distinct variable disease
course that can include an acute, chronic, inapparent, and sometimes a recrudescent stage of
clinical symptoms.
Two variants of EIAV, PND1 and PND5, that differ in the Principal Neutralizing Domain
(PND) were used in in vitro competition experiments. The principal neutralizing domain is a
variable region of the EIAV surface protein. Variation in the PND plays an important role in the
persistence of EIAV. The PND5 variant of EIAV is an escape variant that arose late in infection
in vivo. In previous studies PND1 was highly sensitive to neutralization by broadly neutralizing
antibodies and PND5 was neutralization resistant (Sponseller et al. (2007)). Variant PND1
has higher infectivity as shown in single round infection assays (Wu et al. (2011)). However,
in multiple round coinfection assays of both PND1 and PND5, where the two viruses are
competitively grown on a monolayer of susceptible cells, there is no significant difference in
fitness of the viruses (Figure 3.1). Two independent experiments showed similar growth rates.
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Figure 3.1 Log10 Viral RNA Copy Number and Multiplicity of Infection (MOI) vs Time during
the exponential growth phase of two experiments. Virus fitness appears equal
among variants as indicated by the equal slopes in the growth curves (Wu et al.
(2011)).
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The purpose of the competition experiments is to determine if variants with different sen-
sitivity to neutralization also differ in replicative capacity. In this article we describe an Agent
Based Model (ABM) of the in vitro competition experiments. This ABM has a spatial com-
ponent which enables the model to account for cell associated spread and cell free spread of
EIAV. Cell associated spread of virus is an emerging and progressively accepted mode of virus
transmission shared by viruses such as HIV and EIAV. Cell associated spread is the spread of
infection between an infected cell and a contacting uninfected cell. Virus spread in this manner
may occur independently of the virus surface protein in a way that may allow the virus to
evade detection by the host immune system (Sattentau (2008)). Wu et al. (2011) report that
the rate of cell associated spread can be 3000 fold higher than that of cell free spread. The
high occurrence of cell associated spread may mask cell free infectivity differences between the
viruses. We hypothesize this masking to be the reason for the apparently equal growth rates
in the competition assays despite the different sensitivity to neutralization.
The focus of this chapter is estimating the parameters of the ABM so that the model can
be used to inform on characteristics of the in vitro experiments. Estimating infection rates of
both variants is key to determining if there is a significant difference in replication capacity
among the variants in vitro after accounting for both modes of viral spread. Parameters are
estimated through the use of Markov Chain Monte Carlo (MCMC) methods. Due to the
iterative nature of the MCMC, direct simulation from the ABM is too slow. We use Gaussian
Process models as fast surrogate models to the ABM. Gaussian Process models are flexible
nonparametric models that are commonly used to model computer code output (Kennedy and
O’Hagan (2001)). Posterior distributions of the parameters are then used to check for any
differences in replication capacity among the EIAV variants. Results suggest that although the
rate of cell associated spread is more than that of cell free spread, there is not a significant
difference among the cell free spread rates of the two variants.
3.2 Competition Experiment Data
Direct growth competition experiments were performed with the PND1 and PND5 variants
of EIAV. Equine dermis cells (ED; ATCC CCL57), an EIAV susceptible cell line, growing in
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12 and 24-well plates were inoculated with PND1 and PND5 virus stocks. Supernatant and
cells were collected at specific days after inoculation in which virus copy number and provirus
copy number were measured. A provirus is the form of the virus that has integrated into
the host cell’s genome. Provirus copy number gives an indication of the number of infected
cells. Virus copy number is a measurement of the number of viral RNA copies detected in
the supernatant, i.e. outside of the cells. Data were observed on different wells for each time
point making observations essentially independent across time. The data used come from two
different groups of experiments with identifiers 82-58 and 82-112. Both experiments used the
same virus stocks to inoculate the susceptible cells. Experiments 82-58 used 24 well plates and
experiments 82-112 used 12 well plates. Cells were inoculated in a mono infection of PND1 or
PND5 and in a dual infection of both PND variants. Each inoculation was performed in two
plates in duplicate.
Competition experiments 82-58 ED cells were inoculated with virus stocks normalized
by multiplicity of infection (MOI) 0.001 for each variant. Multiplicity of infection is the ratio
of infectious virus to susceptible cells. Duplicate measurements were taken from wells on two
plates every three days. Replication kinetics of the PND variants seemed unaffected by being in
a dual or mono infection. Combining data results in N58 = 4 averaged replicate measurements
of provirus copy number and virus copy number at each time point, two from the respective
mono infections and two from the dual infection. Data from the experiment are shown in
Figure 3.2.
Let Y it = (yi1t, yi5t)
′ be the mean observed log provirus copy numbers from replicate
experiment i at time t where yi1t and yi5t are the mean log provirus copy number of PND1
and PND5 respectively. Let Zit = (zi1t, zi5t)
′ be the mean observed log virus copy numbers
from replicate experiment i at time t where zi1t and zi5t are the mean log virus copy number
of PND1 and PND5 respectively. We then model Y it and Zit as the following,
Y it | µ∗t , σ21 ∼ N2(µ∗t , σ21I) i = 1, 2, 3, 4 and t = 1, 2, · · · , 7 (3.1)
Zit | µ∗t , σ22, p ∼ N2(pµ∗t , σ22I) i = 1, 2, 3, 4 and t = 1, 2, · · · , 7 (3.2)
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for times t that correspond to 17, 89, 161, 233, 305, 377, and 449 hours. Here µ∗t = (µ∗1t, µ∗5t)′ is
the mean vector for the mean log provirus copy number for PND1 and PND5 at time t, σ21 and
σ22 are the measurement errors for measuring provirus and copy number, and I is a 2×2 identity
matrix. It is assumed that the observed log provirus copy number is directly proportional to
the observed log virus copy number. We model this proportionality with constant p. As seen
in Figure 3.2, the curves for the measured log provirus copy number and those of the log virus
copy number seem to be proportional. This assumption is further justified by the common
assumption that free virus is in a quasi-steady state and that virus production is proportional
to the number of productively infected cells (Wu et al. (2006)).
Competition experiment 82-112 ED cells were inoculated with virus stock normalized
by RNA copy number, 6×105 copies/well. Duplicate measurements of virus copy number were
taken from wells on two plates every day for eight days. Provirus copy number was not measured
in these experiment. Combining data from each mono infection and the dual infection results
in N112 = 4 observations of virus copy number for both PND variants at each time point.
Data from this experiment are shown in Figure 3.3. We assume that the virus copy number is
directly proportional to the unobserved provirus copy number with constant of proportionality,
q. Let Z˜it = (z˜i1t, z˜i5t)
′ be the observed log virus copy numbers for replicate i at time t where
Z˜i1 and Z˜i5 are the log virus copy number of PND1 and PND5. We then model Z˜it as
Z˜it | µ∗t , q, σ23 ∼ N2(qµ∗t , σ23I) i = 1, 2, · · · , 8 and t = 1, 2, · · · , 8. (3.3)
for times t corresponding to 24, 48, 72, 96, 120, 144, 168, and 192 hours. The observed virus
copy numbers in experiment 82-112 are modeled with measurement error σ23.
3.3 Agent Based Model of In Vitro Competition Assays
Agent Based Models are a very flexible class of models that are able to model the dynamics
of complex evolving systems. Our ABM is developed in C++ and simulates the infection and
transmission of two EIA viruses on a monolayer of cells. The purpose of the model is to emulate
the physical experiment with interpretable parameters that can be estimated from experimental
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Figure 3.2 Competition experiment 82-58. Natural log provirus copy number and virus copy
number as a function of time for each virus. Lines indicate the mean for each virus
at respective copy numbers across the sampled time points.
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data. The computer model is designed to simulate, up to a constant of proportionality, the true
mean underlying the biological process that generates the data observed from the laboratory
experiments. A major goal of this study is to estimate the cell-free infectivity difference between
the two viruses. Figures 3.4(a) and 3.4(b) show screen shots of the graphical placement of agents
in the model at two different times after initialization of the model.
3.3.1 State variables and scales
The only agents in the model are the cells. Even though virus activity is modeled, viruses
are not considered as agents. Viruses are only modeled in the system through the infection
status of a cell. The cells in the model are either uninfected or infected. Infected cells are either
infected with PND1 or PND5; dual infection is not possible in the current setup. Once a cell
is infected, it remains infected for the duration of the experiment.
Rather than model the entire well, we model a subset of the entire well with discrete 100×100
toroidal grid. Cells grow and get infected in a monolayer within this discrete subspace. Each
square in the grid is assumed to contain at most one cell. A cell occupying a grid square
interacts with cells in its nearest eight neighborhood. The experiments being modeled used
both 24 and 12 well plates where the well area is 1cm2 and 2cm2 respectively. The scaling factor
for each experiment is considered a random variable and will be estimated. The scaling factor is
a constant of proportionality relating the subset observations observed by the computer model
to the actual scale the experiments are conducted on. The observed mean of log counts by the
computer model is assumed to be proportional to the actual mean of log counts observed in the
experiments due to the scaling down in the computer model. In this case, the computer model
would simulate values of µt assuming only biological variation, where µt =
µ∗t
k1
in experiment
82-58 and µt =
µ∗t
k2
in experiment 82-112 for constants of proportionality k1 and k2. Due to
differences in conditions between the experiments, such as the different well sizes used, the
parameter to reflect the scaling is different for each experiment.
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(a) 2 days and 21 hours after initial infection. (b) 8 days and 21 hours after initial infection.
Figure 3.4 Graphic of sample computer model simulation early in infection. White represents
empty space, grey uninfected cells, blue is PND1 infected cells, and green is PND5
infected cells
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3.3.2 Process overview and scheduling
The agents in the model can only divide, or become infected, or remain unchanged, as we
assume that there is no cell death during the course of the experiment. Both uninfected and
infected cells divide. Cell division can only occur if there is space in a cell’s neighborhood not
occupied by another cell. In the case of a cell division event, a cell of the same type is added
randomly into the neighborhood of the dividing cell. Infected cells can infect an uninfected cell
in one of two ways, cell associated infection or cell free infection. An infected cell can infect an
uninfected cell by cell associated infection only if that uninfected cell is in the neighborhood of
the infected cell. Through cell free infection, an infected cell can infect any uninfected cell on
the grid.
The doubling rate of the cells is estimated from in vitro cell growth assays. The assays tested
the same cell type used in the competition experiments in various experimental configurations.
There were four groups of growth assays labeled 82-60, 82-191A, 82-191B, and CJ. In 82-60,
growth medium was seeded with 200,000 ED cells in a 24 well plate. Cells were measured once
a day and half of the medium was changed each day. In 82-191A, growth medium was seeded
with 200,000 ED cells in both 12 and 24 well plates. Cells were measured each day without
changing the medium. In 82-191B, growth medium in 12 and 24 well plates was seeded with
190,000 ED cells. Measurements were taken daily with a daily full growth medium change. In
CJ, the assays used 6 and 12 well plates that differed in seeding amount. In the 6 well plate,
medium was seeded with 150,000 cells and measurements were taken daily. The 12 well plate
was seeded with 100,000 ED cells and measurements were taken daily. The doubling rate in
each assay was estimated during the exponential growth phase of the respective growth curves.
The doubling times from the growth competition assays are listed in Table 3.1. The rate of cell
division used in the ABM is the average doubling rate from the assays, 20.70 hours. Klevjer-
Anderson et al. (1979) also measured the population doubling rate of the same equine dermal
cells both in the presence of persistent EIAV infection and when uninfected. The population
doubling time determined from the log portion of the cell growth curve in these assays were 21
and 20 hours for uninfected and EIAV infected cells respectively. This result is consistent with
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the mean doubling rate from the cell growth assays and supports our assumption that growth
rate is unaffected by infection.
Each agent, or cell, in the model has information about the type of events it can perform and
the time in which these events will be performed. Each cell in the model possesses knowledge
about itself and its neighborhood. Each cell is aware of its infection status, the number of
uninfected and infected cells in its neighborhood, and the next time in which it can experience
some event. All cells divide at the same rate. The cells are programmed to exhibit contact
inhibition, in which a cell completely surrounded by other cells will not divide. A cell is
considered inhibited by contact when all eight spaces in its neighborhood are occupied by cells.
The rate of cell associated spread is modeled as being the same for both PND1 and PND5
infected cells.
The model is initialized with 2000 uninfected cells that are randomly seeded into the grid
space. The number of initially infected cells is not directly observed in the competition ex-
periments. Specific volumes of each virus stock are used to inoculate the susceptible cells.
Define F1j(0) and F5j(0) to be the number of cells initially infected with PND1 and PND5
respectively. We model the initial number of infected cells with a Gamma distribution that
has mean E[F1j(0)] = ψ4V1j and variance V ar[F1j(0)] = σ
2
ffu for PND1 infected cells and mean
E[F5j(0)] = ψ5V5j and variance V ar[F5j(0)] = σ
2
ffu for PND5 infected cells, where j indexes
competition experiment. Parameters ψ4 and ψ5 are input parameters to the computer model
that represent the FFU/µl for each virus stock. The two competition experiments had different
volumes of each virus stock added. The virus stock volume in experiment j for virus variant
i is Vij . The virus stock volumes for PND1 and PND5 in experiment 82-58 were 7.04 µl and
12.5 µl respectively. The virus stock volumes for PND1 and PND5 in experiment 82-112 were
15 µl and 7 µl respectively. Variance σ2ffu is estimated using data collected from experiments
performed on the virus stocks used for the competition experiments. In the stock experiments,
three aliquots each of the PND1 and PND5 stocks, labeled 82-4, 82-99A, and 82-99B, were
tested for FFU/µl in four to eight replicates. These data are displayed in Figure 3.5. A mixed
linear model was fit to this data with a random effect for aliquot and measurement error. The
estimated measurement error is used as the estimate for σ2ffu.
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Table 3.1 Chart of doubling times from ED Cell Growth Assays
Label Well Size Seeding Size Doubling Time (hrs) Daily Medium Change
82-60 24 200000 11.72 50%
82-191A 12 200000 14.33 0%
82-191A 24 200000 19.79 0%
82-191B 12 190000 20.42 100%
82-191B 24 190000 30.47 100%
CJ 6 150000 22.59 0%
CJ 12 100000 25.60 0%
Mean 20.70
SD 6.39
Table 3.2 Table of parameters
Parameters Description
ψ3 × ψ1 Rate of Cell Free Infection of PND1
ψ3 × ψ1 × ψ2 Rate of Cell Free Infection of PND5
ψ3 Rate of Cell Associated Spread
ψ4 Initial FFU/µl, in PND1 Virus Stock
ψ5 Initial FFU/µl, in PND5 Virus Stock
k1 Scale Factor Exp 82-58
k2 Scale Factor Exp 82-112
p Virus Copy Number:Provirus Ratio Exp 82-58
q Virus Copy Number:Provirus Ratio Exp 82-112
µk Hyper Prior mean of k1
σ21 Error in measuring Provirus Copy No. in Exp 82-58
σ22 Error in measuring Virus Copy No. in Exp 82-58
σ23 Error in measuring Provirus Copy No. in Exp 82-112
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Figure 3.5 Average FFU/µl with ± 2 standard deviation as estimated from the mixed linear
model.
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Each event occurs in time Tevent, where Tevent is modeled as following an exponential
distribution with mean from the respective event rates in Table 3.2. At time t = 0, the
agents in the model are initialized with all necessary event times. The model then proceeds by
executing the event with the minimum event time. Time is then advanced to t = t+min(Tevent)
and all current event times are updated. The updating of event timers involves decrementing
the current timers by min(Tevent) and resetting some event timers to reflect changes that may
have occurred during the most recently occurring event. During cell division events, new cells
are created and their timers are initialized and the divide timer of the dividing cell is reset.
During a cell free infection event, an uninfected cell is chosen at random and becomes infected.
During a cell associated spread event, a randomly chosen uninfected cell in the neighborhood
of the cell scheduled to infect is then infected. During infection events, newly infected cells
will be initialized with timers that reflect the time to perform cell associated infection and cell
free infection of the appropriate type. The cell that performed the infection, has its respective
infection timer reset. Observations from the model are recorded every time an event is executed.
At the time of execution, the number of uninfected cells, PND1 infected cells, PND5 infected
cells, and the elapsed time are recorded.
3.4 Statistical Methods
The main focus is to estimate the parameters of the ABM using data observed from the
competition assays. Computer model calibration is the process of adjusting the computer model
parameters so that the model fits actual observed data. We present a Bayesian approach to
estimate the unknown parameters of the ABM. In this Bayesian approach, a fast substitute
model for the computer model is needed. Gaussian Process (GP) models are used as the surro-
gate model for the ABM. We fit the data to the GP models that now serve as our approximate
computer model.
3.4.1 Gaussian Process Emulation
For the purposes of computer model parameter estimation, we need a way to simulate from
the computer model in a faster manner. Gaussian Process emulation is a tool that is increasingly
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used to model the output of computer experiments (Kennedy and O’Hagan (2001)). The GP
emulator is fitted to the computer model using set of nd inputs, Ψ = (ψ1,ψ2, . . . ,ψnd)
′, called
the design matrix. Each row of Ψ is a fully specified set of parameters for the computer model
such that ψi = (ψi1, ψi2, ψi3, ψi4, ψi5). To emulate the computer model, we model the computer
model outputs, µt, with independent Gaussian process models at each time point.
3.4.1.1 Experimental Design
The choice of input values for the design matrix is a question of experimental design.
Optimal experimental designs are available that focus on minimizing some statistic of the data.
There are designs that are more explorative and focus on exploring the domain of the variables.
We consider the use of a space filling latin hypercube design of size nd. A Latin Hypercube
Sampling design is a method of selecting input variables for computer experiments such that all
sections of the design space are represented (McKay et al. (1979)). The space filling property of
the Latin Hypercube design is appealing in this application when the desire is the estimation of
input parameters since the location in the parameter space is unknown. The Latin Hypercube
design ensures that points are marginally spaced evenly over values of each input variable
(Santner et al. (2003)).
3.4.1.2 Gaussian process model
Gaussian process models are used as interpolators of a response and are determined by speci-
fication of a mean and correlation function. Consider the mechanism that generates the stochas-
tic response as being one that is deterministic with additional variation due to stochasticity. We
assume the mean of the observations are representative of the deterministic portion and model
this with a Gaussian process. The stochastic portion of the output is then modeled indepen-
dently with a polynomial regression model. For input vectors ψ1,ψ2, . . . ,ψnd , consider outputs
µ1,µ2, . . . ,µnd , where µj = (µ1j , µ2j , . . . , µrj) are the r ≥ 2 replicate observations from the
computer model corresponding to ψj . Let µ¯j =
1
r
∑r
i=1 µij and s
2
j =
1
r−1
∑r
i=1(µij−µ¯j)2 be the
sample mean and variance across replicate observations of the computer model at input vector
ψj . A Gaussian process model with constant mean vector M and variance matrix Σ = σ
2
GPK
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is fit to µ¯ = (µ¯1, µ¯2, . . . , µ¯nd). For function m(·), M = (m(ψ1),m(ψ2), . . . ,m(ψnd))′. where
m(ψi) = m(ψj) for all i and j. Variation term σ
2
GP is the unconditional variance of the
computer model output. Matrix K is the correlation matrix that has ijth element
K(µ¯i, µ¯j) = exp
{
−
5∑
k=1
bk
(
ψ
(i)
k − ψ(j)k
)2}
(3.4)
where K(·, ·) is the correlation function known as the Squared Exponential or Gaussian corrla-
tion function. The stochastic variation is estimated using a polynomial model such that
log s2i = f(ψi) +  (3.5)
where s2i is the sample variance within replicate runs of the computer model corresponding to
input vector ψi. The polynomial model is a second order model such that
f(ψi) = f(ψi1, ψi2, . . . , ψi5) = β0 +
5∑
j=1
βjψij +
5∑
j=1
βjjψ
2
ij +
4∑
j=1
5∑
k<j
βjkψijψik. (3.6)
The covariates of the model are estimated using least squares estimation. The regression model
of the stochastic variation is an extension of the so-called nugget term and accounts for the
stochasticity in the computer model (Santner et al. (2003)).
The Gaussian process predictive distribution of µ(·) at a new input vector ψnew is normal
with mean g1(ψ
new) and variance g2(ψ
new).
g1(ψ
new) = E[µ(ψnew)] + σ2GPk
TΣ−1(µ¯−M) (3.7)
g2(ψ
new) = σ2GP + τ
2
ψnew − σ4GPkTΣ−1k (3.8)
Vector k = (k1, k2, . . . , knd)
′ is the correlation vector between the µ¯new, generated from ψnew,
and the vector of observed sample means, µ¯, where kj = K(µ¯new, µ¯j) following from Equa-
tion (3.4). The term τ2ψnew = exp(f(ψ
new))r−1 is the predicted additional variance due to
stochasticity where function f(·) is the second order response surface model defined in Equa-
tion (3.6).
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3.4.2 Bayesian Model
3.4.2.1 Likelihood
The data collected are assumed to all follow normal distributions. The likelihood at time t
would then be the product of the following distributions.
f1(Yt | k1,µt, σ21) =
N58∏
i=1
1
2piσ21
exp
{
−σ
−2
1
2
(Yit − k1µt)′ (Yit − k1µt)
}
(3.9)
f2(Zt | k1, p,µt, σ22) =
N58∏
i=1
1
2piσ22
exp
{
−σ
−2
2
2
(Zit − k1pµt)′ (Zit − k1pµt)
}
(3.10)
f3(Z˜t | k∗2,µt, σ23) =
N112∏
i=1
1
2piσ23
exp
{
−σ
−2
3
2
(
Z˜it − k∗2µt
)′ (
Z˜it − k∗2µt
)}
(3.11)
Vector Yt is the observed log provirus copy numbers at time t for all experimental replicates
i in experiment 82-58. Vector Zt is the observed log virus copy numbers at time t for all
experimental replicates i in experiment 82-58. Vector Z˜t is the observed log virus copy numbers
at time t for all replicates i in experiment 82-112. Constants k2 and q are not identifiable in
the model separately, instead we use k∗2 = k2q.
3.4.2.2 Priors
The prior distribution for 1/σ22 and 1/σ
2
3 are Gamma distributions with shape and rate
parameters 3.401 and 0.2608 respectively. To justify this choice in prior distribution, we used
data from separate experiments, designated 82-16a, 82-16b, and 82-16c. In these experiments,
susceptible cells were coinfected with two variants of EIAV and the virus copy number per
µl was measured at days 3, 4, 5, 7, 9, and 11. Measurements of virus copy number were
taken in duplicate from four separate plates. The data from these experiments are displayed
in Figures 3.6(a) - 3.6(c). A mixed linear model with fixed effects for virus and days post
infection (DPI) and random effects for sub experiment and measurement error was fit to the
data. This model makes no attempt to differentiate two different modes of infection and thus
is appropriate in this context where the main focus is the estimation of measurement error.
The estimate for the inverse error variance was 13.04. Choice of shape and rate of the Gamma
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prior yield a distribution with mean 13.04 and variance 50. Prior distribution for 1/σ21 is a non
informative uniform distribution over the range 0 to 1000.
The prior distribution for the proportionality constant between the observed provirus copy
number and the virus copy number in experiment 82-58, p, is a non informative Uniform
distribution with lower and upper bounds 1 and 1000 respectively. Constant k1 is the scale up
factor relating the output of the computer model to the experimental data in experiment 82-58.
A hierarchical Normal prior with mean µk and variance 1 is placed on k1. A non informative
Uniform prior with lower and upper bounds 0 and 1000 respectively is placed on µk. The
constant of proportionality relating virus copy number in experiment 82-112 to observations
from the computer model, k∗2, has a non informative Uniform prior with lower and upper limits
0 and 1000 respectively.
Computer model input parameters have prior distributions based on information provided
in previous experiments and available information. The parameter describing the difference in
the rates of cell free infection of PND1 and PND5, ψ2, has a Gamma distribution with shape and
rate parameters 1 and 1/4 respectively. These numbers are justified by results of a single round
infectivity assay developed to compare the rates of cell free infection of the two EIA variants
(Wu et al. (2011)). Data from this assay showed that PND1 has a rate of cell free infection
that is 4 fold higher than that of PND5. The prior distribution for the rate of cell associated
spread, ψ3, was developed through pilot runs of the computer model and through information
known about the rate of cell associated spread in HIV. Several runs of the computer simulation
model provided output that was visually comparable to experimental data when the rate of
cell associated infection was in the range covered by the prior. It has also been observed that
cell associated spread of HIV can occur in 32 hours (Hu¨bner et al. (2009)). In the experiment
in which this result was observed, continuous long term imaging was performed. It revealed
that an infected cell synapsed with a susceptible cell for 18 hours and at 32 hours there was a
productive infection. The proposed prior reflects this result near the center with spread over
the range of discovery from the computer model pilot runs. The mean number of infected cells
at the initial stage of the experiment was not directly observed nor specified. Experiment 82-58
was initiated using equal FFU for each virus, which was subjected to measurement error. The
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Figure 3.6 Log Virus Copy Number/µl by DPI in Experiment 82-16
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prior for ψ5 and ψ6 is uniform over the range 0 to 100. Bounds for the prior are intended to
have the prior distribution be vaguely informative. Pilot runs of the computer model with ψ5
and ψ6 within this range present reasonable output. The parameter relating the rates of cell
free infection to cell associated spread, ψ1 has a non informative uniform prior.
Yit | µt, σ21, k1 ∼ N2(k1µt, σ21I)
Zit | µt, σ22, p, k1 ∼ N2(k1pµt, σ22I)
Z˜it | µ∗t , σ23, k∗2 ∼ N2(k∗2µt, σ23I)
1/σ21 ∼ Uniform(0, 1000)
1/σ22 ∼ Gamma(3.401, 0.2608)
1/σ23 ∼ Gamma(3.401, 0.2608)
µ | ψnew ∼ N (g1(ψnew), g2(ψnew))
k1 ∼ N(µk, 1)
µk ∼ Uniform(0, 1000) (3.12)
p ∼ Uniform(1, 1000)
k∗2 ∼ Uniform(0, 1000)
ψ1 ∼ Uniform(1, 100)
ψ2 ∼ Gamma(1, 0.25)
ψ3 ∼ Gamma(16, 0.5)
ψ4 ∼ Uniform(0, 100)
ψ5 ∼ Uniform(0, 100)
3.4.2.3 Posterior
Due to conjugate prior specification, the full conditional posterior for the mean log infected
cell counts (µ’s), inverse measurement errors (1/σ22, 1/σ
2
3), and the scaling constant in exper-
iment 82-58 (k1) all have a closed form distribution. The vector of mean infected cells for a
single PND variant v = 1, 5 at all times t = 1, 2, · · · , T , µv = (µv1, µv2, · · · , µvT ), has a Mul-
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tivariate Normal posterior distribution. For times t in experiment 82-58, the full conditional
posterior, pi(µv | Yv,Zv, σ21, σ22, k1, p,ψ), is Normal with posterior mean and variance indicated
in Equation (3.13).
µpost = Σpost
[
N58k1
(
Σ−11 Y¯v + pΣ
−1
2 Z¯v
)
+ Σ−10 µ0
]
Σpost =
[
Σ−10 +N58k
2
1
(
Σ−11 + p
2Σ−12
)]−1
(3.13)
Here, µ0 = (g11(ψ), g12(ψ), · · · , g1T (ψ))′, Σ0 = diag (g21(ψ), g22(ψ), · · · , g2T (ψ)), Σ1 = σ21I
and Σ2 = σ
2
2I. Vectors Y¯v and Z¯v are the sample means of observed log provirus copy number
and log virus copy number averaged by sample time. For times t in experiment 82-112, the
full conditional posterior, pi(µv | Z˜v, σ23, k∗2,ψ) is Normal with posterior mean and variance as
indicated in Equation (3.14).
µpost = Σpost
[
N112k
∗
2Σ
−1
3
¯˜
Zv + Σ
−1
0 µ0
]
Σpost =
[
Σ−10 +N112(k
∗
2)
2Σ−13
]−1
(3.14)
Variance matrix Σ3 = σ
2
3I and
¯˜
Zv is the vector of sample means from the observed log virus
copy numbers for virus v from experiment 82-112.
The full conditional posterior for 1/σ22 is a Gamma distribution with shape and rate pa-
rameters α2 and β2 respectively.
α2 = 3.401 + T58N58
β2 = 0.2608 +
1
2
[
T58∑
t=1
N58∑
i=1
[
(Zit − kpµt)′(Zit − kpµt)
]]
(3.15)
The full condition posterior for 1/σ23 is a Gamma distribution with shape and rate parameters
α3 and β3 respectively.
ατ = 3.401 + T112N112
βτ = 0.2608 +
1
2
[
T112∑
t=1
N112∑
i=1
(Z˜it − k∗2µt)′(Z˜it − k∗2µt)
]
(3.16)
The full conditional posterior distribution for the scaling constant in experiment 82-58, k1, is
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normal with mean µpost,k1 and variance σ
2
post,k1
.
σ2post,k =
((
N58
σ21
+
N58p
2
σ22
) T58∑
t=1
µ′tµt + 1
)−1
(3.17)
µpost,k1 =
(
1
σ21
T58∑
t=1
N58∑
i=1
Y′itµt +
p
σ22
T58∑
t=1
N58∑
i=1
Z′itµt + µk
)
σ2post,k1
3.4.2.4 Markov Chain Monte Carlo
Markov Chain Monte Carlo (MCMC) is a sampling method that draws samples from a
probability distribution up to a constant of proportionality by running Markov chains for long
lengths (Gilks et al. (1996)). There are many methods to construct a Markov chain. We
use a Metropolis-Hastings within Gibbs sampling algorithm. Gibbs sampling is an algorithm
for sampling a subset of parameters at a time by sampling from full conditional distributions
(Gelfand et al. (1990)). The Metropolis-Hastings algorithm uses a proposal distribution to
generate candidate samples that are either accepted or rejected. This method can be used
within Gibbs sampling to sample from full conditional distributions that are not simple to
sample from directly.
3.5 Results
3.5.1 Fitting Gaussian Process Models
To fit the Gaussian process models, a latin hypercube sample of size nd = 150 was created
using input values sampled uniformly for each parameter subject to the bounds indicated in
Equations (3.18) - (3.22). A latin hypercube sampling design is a space filling design that
ensures that all sections of the design space are represented (McKay et al. (1979)). The design
is displayed in Figure 3.7. Observations are both independent from each other and independent
across time. To emulate the ABM with this independence structure, for every combination of
log infected cell count in each experiment and sampled time, the ABM model was run at each of
the 150 input vectors to obtain r = 40 replicate observations of log infected cell counts at each
time in each experiment. The mean across replicate observations for each set of outputs from
the ABM are used to fit 30 independent Gaussian process models. R package mlegp (Dancik
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(2011)) is used to obtain maximum likelihood estimates of the GP models. The maximum
likelihood estimates of the Gaussian process parameters are included in Tables 3.3 - 3.6. The
sample variances at each input vector are used as estimates of the stochastic variance in the
model and used to fit the second order polynomial regression models from Equation 3.6
1 ≤ ψ1 ≤ 400 (3.18)
0 < ψ2 ≤ 20 (3.19)
0 < ψ3 ≤ 60 (3.20)
1 ≤ ψ4 ≤ 60 (3.21)
1 ≤ ψ5 ≤ 60 (3.22)
3.5.2 MCMC
A Markov chain with stationary distribution pi(ψ,µ, σ21, σ
2
2, σ
2
3, k1, p, k
∗
2, µk | Y,Z, Z˜) was
sampled using a Metropolis Hastings within Gibbs sampling scheme. The chain was sampled
for 100000 iterations using 40000 as a burn in period. Four chains were sampled and all seemed
to converge to the same distribution. Posterior summary results are displayed in Table 3.11.
Multiple chains initialized at different values were sampled to verify convergence to the station-
ary distribution. The Gelman-Rubin Statistic for each variable was close to 1 indicating that
there is evidence that each chain converged to the same distribution
The data largely informed on distributions of the computer model input variables, as well
as the other posterior variables, as compared to the prior distributions. Even with the usage
of diffuse and non informative priors, the marginal posterior distributions were unimodal and
informative. The model assumes that the rate of cell associated spread of the virus is equal
for both variants. Differences in replicative capacity is thus being modeled by the rates of cell
free infection. Input parameter ψ2 is the proportional difference of cell free spread of variant
PND1 to variant PND5. The posterior mean of ψ2 is 2.479, which indicates that PND1 has
a higher rate of cell free infection than PND5. However, the 95% credible set for ψ2 includes
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Figure 3.7 Scatter plot matrix of latin hypercube design used to fit the Gaussian process
models.
Table 3.3 Maximum likelihood estimates of GP parameters for GP models of log PND1 infected cell count in
experiment 82-58
t 17 89 161 233 305 377 449
b1 2.845e-06 1.125e-06 1.115e-07 5.002e-06 1.542e-30 3.823e-10 4.915e-09
b2 1.551e-06 0.001632 0.003438 1.753e-10 0.001248 0.01181 0.02694
b3 0.003038 0.0006344 0.001238 0.0003858 0.0001668 7.486e-05 3.031e-05
b4 0.006106 0.005001 0.008537 0.02787 0.02991 0.02006 0.006014
b5 3.763e-07 9.524e-06 5.904e-10 1.847e-09 3.74e-06 2.995e-05 0.0003867
M 6.73 8.555 8.991 8.928 9.06 9.058 9.122
σ2GP 2.3 1.062 0.3438 0.3566 0.347 0.09457 0.03152
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Table 3.4 Maximum likelihood estimates of GP parameters for GP models of log PND5 infected cell count in
experiment 82-58
t 17 89 161 233 305 377 449
b1 2.706e-09 1.385e-06 2.308e-07 1.647e-08 1.032e-05 1.374e-07 2.307e-07
b2 4.213e-06 0.0008255 0.0007247 0.0006049 4.207e-07 1.971e-11 0.0004383
b3 0.001336 0.0004142 0.0006468 0.0004764 4.017 0.001848 0.007046
b4 1.241e-05 5.244e-12 7.798e-09 2.686e-10 5.361e-14 8.39e-08 3.262e-15
b5 0.01581 0.01296 0.03223 0.02549 1.567e-26 0.09524 0.01458
M 7.55 8.605 9.046 9.132 9.196 9.189 9.197
σ2GP 1.619 0.5305 0.09509 0.06247 0.004568 0.002483 0.001315
Table 3.5 Maximum likelihood estimates of GP parameters for GP models of log PND1 infected cell count in
experiment 82-112
t 24 48 72 96 120 144 168 192
b1 4.674e-06 5.07e-08 3.636e-07 1.338e-07 3.341e-06 7.514e-10 4.102e-06 4.539e-10
b2 0.000197 3.285e-06 0.002584 0.003226 4.85e-06 0.002304 1.421e-18 2.512e-05
b3 0.000787 0.001529 0.0006339 0.0007266 0.0005748 0.0006425 0.0006381 0.0002989
b4 0.006674 0.03682 0.005605 0.006583 0.02528 0.02496 0.02965 0.05304
b5 2.318e-06 8.98e-07 3.914e-05 2.579e-05 4.561e-07 3.001e-06 1.12e-11 7.235e-07
M 8.162 8.329 8.702 8.873 8.925 9.048 9.022 8.874
σ2GP 1.169 0.628 0.5433 0.3438 0.2709 0.1631 0.1732 0.3963
Table 3.6 Maximum likelihood estimates of GP parameters for GP models of log PND5 infected cell count in
experiment 82-112
t 24 48 72 96 120 144 168 192
b1 5.603e-09 5.345e-09 1.498e-08 4.035e-08 5.322e-08 6.185e-08 7.592e-08 9.959e-08
b2 9.382e-06 3.328e-05 1.456e-05 3.464e-05 7.772e-05 0.0001717 0.0002357 0.0002406
b3 0.001957 0.0012 0.001049 0.0009612 0.0006709 0.0005879 0.0005643 0.0006241
b4 1.46e-05 2.656e-05 2.611e-05 7.844e-06 5.671e-06 3.1e-06 2.465e-06 2.814e-06
b5 0.01219 0.02375 0.02965 0.04595 0.05736 0.06809 0.07029 0.0671
M 7.265 7.876 8.231 8.427 8.596 8.729 8.837 8.926
σ2GP 1.995 0.9299 0.7125 0.5072 0.4305 0.3315 0.236 0.1513
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1, referring to the model parameterization in Table 3.2, this indicates that we are not able to
conclude that there is a significant difference in the rates of cell free infection among the two
variants.
3.6 Discussion
We developed a computer model of in vitro competition infection assays of EIAV. This
model takes a unique approach by accounting for the prevalence of both cell free and cell
associated spread of virus. Models of replication fitness similar to that of Wu et al. (2006)
do not attempt to account for the different modes of virus spread. The agent based computer
model was fit to data from multiple experiments. Using data from different experiments proved
to be beneficial in providing more information to inform on the distributions of the posterior
parameters.
The stochastic agent based model proved useful in providing a way to estimate both cell free
and cell associated spread among the two EIAV variants. Although estimation of the computer
model input variables revealed that there was no statistically significant difference in fitness
of PND1 and PND5, as characterized by their respective rates of cell free infection, findings
supported the significant difference in the rates of cell free and cell associated spread. To drive
further improvement of the model, future work and development of the agent based model could
focus on the implications of the modeling choices and configurations used. One such modeling
choice could be the impacts of using data from multiple experiments. When estimating the
parameters of the ABM, we used data from two independent experiments, 82-85 and 82-112.
Although efforts were made to account for differences between the two experiments, it is not
clear if there are interactions between experiment and virus/cell dynamics. The marginal
posterior distribution for ψ1 appears to be bimodal. This could be due to differences in the
virus-cell interaction for cell associated spread in the experiments. Sensitivity of the model to
choices such as the size of the discrete grid space and the usage of a nearest eight neighborhood
structure governing cell division and cell associated spread could be analyzed.
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Figure 3.8 Prior and Posterior Densities for Computer Model Inputs ψ1, ψ2, ψ3, ψ4, and ψ5
Table 3.7 Posterior Summary for mean log virus count for PND1 in experiment 82-58. Pos-
terior mean, standard deviation, upper and lower 95% credible set limits.
HPI 17 81 161 233 305 377 449
Mean 4.458 7 8.477 8.913 8.97 8.959 9.08
SD 0.259 0.166 0.171 0.097 0.128 0.15 0.091
2.5% 3.975 6.672 8.139 8.709 8.708 8.615 8.844
97.5% 4.978 7.324 8.809 9.092 9.205 9.18 9.205
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Table 3.8 Posterior Summary for mean log virus count for PND5 in experiment 82-58. Pos-
terior mean, standard deviation, upper and lower 95% credible set limits.
HPI 17 81 161 233 305 377 449
Mean 4.846 6.833 8.399 8.896 9.202 9.136 9.184
SD 0.233 0.175 0.119 0.069 0.044 0.022 0.015
2.5% 4.405 6.488 8.164 8.753 9.112 9.087 9.155
97.5% 5.311 7.173 8.634 9.024 9.279 9.173 9.214
Table 3.9 Posterior Summary for mean log virus count for PND1 in experiment 82-112. Pos-
terior mean, standard deviation, upper and lower 95% credible set limits.
HPI 24 48 72 96 120 144 168 192
Mean 4.61 5.845 6.62 7.254 8.038 8.522 8.901 9.023
SD 0.126 0.134 0.173 0.168 0.19 0.146 0.097 0.091
2.5% 4.39 5.602 6.327 6.961 7.705 8.234 8.698 8.821
97.5% 4.885 6.132 7.011 7.627 8.458 8.807 9.08 9.18
Table 3.10 Posterior Summary for mean log virus count for PND5 in experiment 82-112.
Posterior mean, standard deviation, upper and lower 95% credible set limits.
HPI 24 48 72 96 120 144 168 192
Mean 3.337 4.794 5.319 6.157 6.612 7.247 7.858 8.013
SD 0.101 0.115 0.122 0.132 0.138 0.145 0.15 0.153
2.5% 3.151 4.583 5.096 5.916 6.36 6.981 7.579 7.729
97.5% 3.553 5.038 5.577 6.438 6.911 7.556 8.174 8.337
Table 3.11 Posterior Summary of 1/σ21, 1/σ
2
2, 1/σ
2
3, k1, k
∗
2, µk, p,ψ
Parameter Mean S.D. 95% Credible Set
1/σ21 2.214 0.636 ( 1.189 , 3.66 )
1/σ22 1.075 0.333 ( 0.576 , 1.868 )
1/σ23 14.121 3.889 ( 6.841 , 22.138 )
k1 1.525 0.016 ( 1.492 , 1.557 )
k∗2 1.651 0.027 ( 1.595 , 1.704 )
µk 1.609 0.679 ( 0.324 , 2.973 )
p 1.362 0.015 ( 1.333 , 1.392 )
ψ1 19.737 11.07 ( 2.902 , 43.661 )
ψ2 2.479 1.356 ( 0.215 , 5.251 )
ψ3 29.776 2.267 ( 25.592 , 34.356 )
ψ4 2.792 0.327 ( 2.189 , 3.454 )
ψ5 2.314 0.392 ( 1.645 , 3.144 )
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Figure 3.14 Marginal posterior densities of µ1t in experiment 82-58
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Figure 3.15 Marginal posterior density of µ5t in experiment 82-58
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Figure 3.16 Marginal posterior densities of µ1t in experiment 82-112
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Figure 3.17 Marginal posterior densities of µ5t in experiment 82-112
65
CHAPTER 4. EMULATING STOCHASTIC AGENT BASED MODEL
OF IN VITRO EIAV INFECTION ASSAY
Computers are commonly used to model that which is difficult or impossible to observe
experimentally. There are many benefits to using computers to model scientific phenomena and
physical processes. Computer models can simulate complex processes that may be financially
costly or impossible to create in a controlled environment. In cases such as weather modeling,
computers can actually simulate weather conditions at the will of the experimenters, which
would be impossible to create in reality.
Computer models are nothing more than computer codes designed to simulate outcomes
of a process as determined by the parameters and actions governed by the code. There are
many types of computer models. Two major classifications of computer models are determin-
istic computer models and stochastic computer models. In a deterministic computer model,
code executed with the same input will have the same output for each execution of the code.
Considering a process without natural or physical variation can be appealing in some cases. De-
terministic computer models offer a simplified way to view any process in which experimenters
can study expected outcomes without the complications of the naturally existent variability.
However, in some applications, the natural variability plays an important role in conducting
sensitivity analysis and data fitting. In such cases, models need to be able to reflect the natural
or physical variation that is inherent in these processes. A stochastic computer model differs
from a deterministic model in the property that repeated runs of the code at the same input
can have different outcomes. This added complexity allows experimenters to develop models
that can realistically resemble the processes they desire to model.
In either class of model, there often arises the need to use the model in fast manner.
When studying the behavior of the model one may need to execute the model under various
66
conditions many times. It may often be the case that the computer model is very complex
and computationally extensive with lengthy run times. When situations call for such uses of
the computer model, an efficient way of using the model is required. One way of using the
computer model in a fast and efficient way is to emulate the computer model. Computer
model emulation is the approximation of the computer model with a statistical model. Using
approximations to computer models has been also described as using meta models or surrogate
computer models. We propose to model the variation present in stochastic computer model
outputs by using polynomial regression models. In what follows, we review currently existing
methods for modeling stochastic computer code output, then we demonstrate the usage of an
independent polynomial regression model on data from a stochastic agent based computer code
of in vitro Equine Infections Anemia Virus competition experiments.
4.1 Related work
The goal in computer model emulation is to use computer model input and corresponding
output to build a statistical model that is able to predict computer model output at unobserved
input values. Gaussian Processes appear frequently in the literature for generating output
based on computer experiments (Santner et al. (2003); Dancik (2008); Ankenman et al. (2010);
Kennedy and O’Hagan (2001)). The Gaussian Process is determined by its mean and covariance
functions. Consider a computer code with a set of inputs x ∈ Rp, where p ≥ 1, and define
the output of the code to be y(x) ∈ R1. If y(x) is said to be a Gaussian Process, then for
any set of input vectors, X = (x1,x2, · · · ,xn)′, the vector Y (X) = (y(x1), y(x2), · · · , y(xn))′
has a n ≥ 1 dimensional multivariate Gaussian distribution. Let µ(·) be a function, such that
the mean vector of the Gaussian distribution is µx = (µ(x1), µ(x2), . . . , µ(xn))
′. The variance
matrix takes form V = σ2GPK(·, ·) where σ2GP is the non conditional variation of the Gaussian
process and K(xi,xj) = Cor(y(xi), y(xj)), for all xi,xj ∈ X. A frequent model of computer
model output is a standard regression model of the mean with a Gaussian Process to account
for the residual variance (Santner et al. (2003)).
y(x) =
p∑
k=1
fk(x)βk + Z(x) (4.1)
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Functions (f1(x), f2(x), · · · , fp(x)) are known regression functions, (β1, β2, · · · , βp) are un-
known regression coefficients and Z(x) is a mean zero Gaussian process with some correlation
function K(·, ·). The correlation function has distinct properties that allow for flexibility in
its specification. There are common families of the correlation function, such as the Power
family (4.2) and the Mate´rn correlation function (4.3).
K(xi,xj) = exp
{
−‖xi − xj‖
p
θ
}
(4.2)
K(xi,xj) =
1
Γ(ν)2ν−1
(
2
√
ν ‖xi − xj‖
θ
)ν
Kν
(
2
√
ν ‖xi − xj‖
θ
)
(4.3)
In the Power family when 0 < p ≤ 2, the correlation function is continuous at the origin. In
the Mate´rn family, Kν(·) is the modified Bessel function of order ν and θ is a scale parameter.
Any choice of correlation function must have the following properties,
K(xi,xj) ≤ 1 ∀ i, j (4.4)
K(xi,xi) ≥ K(xi,xj) ∀ i, j (4.5)
K(xi,xj) = K(xj ,xi) (4.6)
There has been much work and exploration done with approximating deterministic com-
puter models. Kennedy and O’Hagan (2001) propose to model deterministic code using Gaus-
sian Processes. The difficulty in emulating stochastic computer codes stems from the fact that
they include variability that is introduced through randomization. One could naively model
a stochastic computer model as though it were deterministic. This could be accomplished
through averaging over the responses from numerous simulations and treating the average of
the responses as the deterministic response that is to be modeled. This has obvious short-
comings. To do this one would need to simulate the model a large number of times to be
sure that this averaged response is near the true mean of the responses. Making the modeling
choice to treat the average response as a deterministic surface results in the loss of ability to
account for the inherent variability in the model. The natural variability that is included in a
stochastic model is usually needed in order to accurately account for what would be observed
in actual physical experiments. Dismissing this fundamental property of the computer model,
could prove to be an unacceptable modeling choice. This type of modeling is inadequate for
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emulating stochastic computer models. Stochastic computer codes can have responses that
vary simplistically or that vary in a complex manner. Using a data set with added noise we
demonstrate some proposed efforts to account for stochasticity when emulating a process.
4.1.1 Motorcycle crash dataset
Schmidt et al. (1981) has a motorcycle dataset from simulation studies exploring the safety
of motorcycle helmets. The data contain head acceleration observations as a function of time
since an impact. The data are shown in Figure 4.1 with a Gaussian process model mean fit
to the data. The time variable has been normalized to the unit interval. Omitting the details
of this particular Gaussian process fit, consider the mean a function f(·) of time xi to be
the underlying process that generates head acceleration observations. To add heteroscedastic
variation to this process, noise was added. Replicate observations were generated from the
model
yij = f(xi) + ij (4.7)
where yij is the j
th replicate acceleration observation at time xi for i = 1, 2, . . . , 90 and j =
1, 2, . . . , 10. The noise in the model is ij such that it follows a normal distribution with mean
0 and standard deviation (sin(pixi − 0.4) + 0.4) ∗ 50. A random sample of size 45 yi·’s are then
used to fit the upcoming Gaussian process models and the remaining data will demonstrate
the models’ adequacy.
4.1.2 Stochastic variation models
Extensions to the Gaussian process model have been proposed that use an additional fixed
variation term, commonly referred to as a nugget, to account for the additional variation in
a stochastic model. In Gaussian process models that incorporate a constant nugget term, the
variance matrix takes on a form such as
V1 = σ
2
GPK(·, ·) + σ2NI (4.8)
where σ2N is the so called nugget variation term and I is an N ×N identity matrix. The fixed
nugget does not account for heteroscedastic variation across different computer model input
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Figure 4.1 Gaussian process model fit to motorcycle crash dataset.
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Figure 4.2 Gaussian process model with fixed scalar nugget fit to noisy motorcycle crash
dataset
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values. As seen in Figure 4.2, the Gaussian process with the stationary variance poorly accounts
for the variation in the response when the variation is comparatively larger or smaller. Dancik
(2008) and Ankenman et al. (2010) propose Gaussian process models to include a nugget term
that can vary, in which they estimate using sample variances at replicated runs of the code
at each set of computer model inputs. Dancik (2008) estimates the nugget variation up to a
multiplicative constant. Variation in the Gaussian process is then modeled with covariance
matrix
V2 = σ
2
GP (K(·, ·) + αNs). (4.9)
Ns is the user-specified nugget matrix up to a multiplicative constant α. In the absence of
exact knowledge of the stochastic behavior of the computer model output, Ns is recommended
to be based on sample variances. In this case, Ns would be a diagonal matrix with the i
th
diagonal element equal to the sample variance of the computer model output using input xi.
Ankenman et al. (2010) proposed to model the variation with covariance matrix
V3 = σ
2
GPK(·, ·) + Σe. (4.10)
Variation component Σe accounts for the intrinsic noise and has ij
th element as Cov
[
vi
ri
,
vj
rj
]
,
where vi and ri represents the intrinsic variation and number of replicates associated with input
vector xi respectively. Ankenman et al. (2010) offer that without introducing prediction bias,
Σe can be modeled as Diag
[
vˆ1
r1
, vˆ2r2 , . . . ,
vˆN
rN
]
. Since vi is unobservable, the sample variance is
used as an estimate of vi.
vˆi = s
2
i =
1
ri − 1
ri∑
j=1
(yij − y¯i·)2 (4.11)
Here, yij is the j
th replicate observation from input xi and y¯i· is the average of the observed
replicates at input vector xi.
In both cases, predictions at untried computer model input vectors would have to rely
on the correlation function to define the nature of the stochastic variation at untried input
vectors. It is through the untried vectors proximity to tried input vectors that the nature of
the stochastic variation is established. This type of smoothing may not represent the stochastic
variation surface well in some situations. Figures 4.3 and 4.4, show Gaussian process models
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Figure 4.3 Gaussian process model fit to motorcycle crash dataset. Confidence bands rep-
resent the lower and upper 2.5% of the Gaussian process predictive distribution
using variance matrix in Equation (4.9)
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Figure 4.4 Gaussian process model fit to motorcycle crash dataset. Confidence bands rep-
resent the lower and upper 2.5% of the Gaussian process predictive distribution
using variance matrix in Equation (4.10)
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with constant mean vectors and variance matrices as proposed by Dancik (2008) and Ankenman
et al. (2010) respectively. A constant mean vector µx = (µ(x1), µ(x2), . . . , µ(xn))
′ implies that
µ(xi) = µ(xj) ∀ i, j. The Gaussian process models are fit to the y¯i·’s, within replicate means,
sampled from the simulated motorcycle crash data. Each Gaussian process model was fit
using R package mlegp (Dancik (2011)). Given an untried input xnew, the Gaussian process
predictive distribution with variance matrix V , from either Equation 4.9 or 4.10, has mean
µ(xnew) + σ2GPk
′V −1(y¯−µx) and variance σ2GP − σ4GPk′V −1k where y¯ = (y¯1·, y¯2·, . . . , y¯n·)′ and
vector k = K(xnew,x) is the correlation between xnew and x = (x1, x2, . . . , xn). This model
is an improvement over the fixed nugget case. There are clear increases and decreases in the
prediction variation along the parameter space of the explanatory variable. However, since the
variation at any unobserved xi is dependent on the relationship established by the correlation
function, the model lacks the ability to predict the variance due to stochasticity.
Gramacy and Lee (2008) proposed Bayesian treed Gaussian process models to model stochas-
tic computer models with heteroscedastic variation. In such models the input space in which
X resides, is partitioned and independent Gaussian process models with fixed nugget terms
are fit to each partition. These partitions are made by binary splits on a single variable. This
approach does not lend itself well to types of heteroscedastic variation that interacts with mul-
tiple dimensions of the input vectors since the partitioning is done only on one variable in the
input space. But serves to be useful in cases where this variation is not a smooth function.
Henderson et al. (2009) make an assumption that the log standard deviation within repli-
cates of the input matrix X is a smooth function of computer model inputs and models this
using a Gaussian Process. This now involves the fitting of two independent Gaussian processes.
One for the mean of the responses and one for the log standard deviation of the responses. Ob-
servations Y = (y1, y2, . . . , yn)
′ are assumed to be normally distributed with mean M and
variance exp(2V4) such that
M ∼ Nn (µx,Σm) (4.12)
and
V4 ∼ Nn (νx,Σv) , (4.13)
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where Σm = σ
2
GPK(·, ·) and Σv = τ2GPQ(·, ·). The Gaussian process models are fit to the vector
of sample means y¯ and the vector of log sample standard deviationsw = (log s1, log s2, . . . , log sn).
The Gaussian process predictive distribution for ynew given an unobserved input x
new is nor-
mally distributed with mean µp and variance σ
2
p.
µp = µ(x
new) + σ2GPk
′Σ−1m (y¯ − µx) (4.14)
σ2p = exp
(
ν(xnew) + τ2GP q
′Σ−1v (w − νx)
)
+ σ2GP − σ4GPk′Σ−1m k (4.15)
4.2 Gaussian Process Prediction
Consider a computer model in the context where for a given input, either scalar or vector
valued, one observes a stochastic output. This output may be vector or scalar valued, but for
the following description, consider a scalar output. Let X = (x1,x2, . . . ,xn)
′ be a n× p matrix
of computer model inputs where xi = (xi1, xi2, . . . , xip) for p input parameters and n computer
model input vectors. Matrix X is referred to as the design matrix. Specification of this matrix
is a question of computer model experimental design and has been discussed in detail by Sacks
et al. (1989) and Santner et al. (2003). We discuss selection of the experimental design in
Section 4.2.2.
Let Z = (z1, z2, . . . , zn)
′ be the n × r matrix of univariate computer model output, where
zi = (zi1, zi2, . . . , zir) is a vector of r replicate observations of the computer model exe-
cuted at input vector xi. Define Z¯ = (z¯1, z¯2, . . . , z¯n) to be the vector of mean observations
where z¯i =
1
r
∑r
j=1 zij is the average over r ≥ 2 replicates from input vector xi. Also define
S = (s21, s
2
2, . . . , s
2
n) to be the vector of sample variances such that s
2
i =
1
r−1
∑r
j=1 (zij − z¯i)2.
Consider the mechanism that generates the stochastic response as being one that is determin-
istic with additional variation due to stochasticity. We assume the mean of the observations
are representative of the deterministic portion and model this with a Gaussian process. The
stochastic portion of the output is then modeled independently with a polynomial regression
model. Given a set of inputs X, the Gaussian process is fit to the vector of mean outputs,
Z¯. The vector of means is then modeled as being jointly Gaussian given X, with mean µ(X)
and variance σ2GPK(·, ·) + ΣN , where ΣN = diag( s
2
1
r ,
s22
r , . . . ,
s2n
r ). We consider the following
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correlation function such that
K(xi,xj) = exp
{
−
p∑
k=1
dk(xik − xjk)2
}
(4.16)
is the ijth element of K(·, ·). This is known as the Squared Exponential or Gaussian corre-
lation function which is commonly used in Gaussian process models. Its appeal comes from
it being infinitely differentiable and that is employs simple squared euclidean distance metric
as a measure of distance between any two input vectors. Range parameters dk determine the
smoothness or magnitude that input xk has on the correlation. If the correlation is believed to
be isotropic then dk = d for all k.
4.2.1 Stochastic Variation Response Surface
Treating the stochastic variation in a computer model as an estimable surface and esti-
mating this surface with a polynomial model provides the ability to quickly make independent
predictions of the stochastic variation at unobserved input vectors unlike the other methods
that rely on the correlation function to inform on the degree of additional variation. Polynomial
regression models are straightforward to fit with an appropriate experimental design. This is
a major factor when comparing methods involving the use of a Gaussian process to model any
computer model with inherent stochasticity. When using a Gaussian process model as a sur-
rogate model for a more complex and computationally extensive process, a fast approximation
that is flexible enough to account for the behaviors of the original process is desired, making
the use of regression models for the variation very reasonable.
The variation response surface of models with non-constant variation across the inputs
can be nonlinear and possibly have interactions across the input space. Define s2i to be the
additional variance in the computer model output at input vector xi due to the stochasticity
in the model. We treat the stochastic variation as a response and model log s2i with a second
order polynomial model. Choice of a second order model to model the log stochastic variation
is motivated by the flexibility of this class of models (Myers and Montgomery (2002)). A
second order model with interaction terms can model surfaces with curvature and the lower
level interactions. Higher or lower order models can be considered based on the complexity of
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the surface or the necessity of accuracy in accounting for the variation. Model selection can be
performed and the significance of model terms can be examined.
log s2i = f(xi1, xi2, . . . , xip) +  (4.17)
The function f(·) is an unknown function of the input vectors and  is a random variable
assumed to have mean 0 and variation τ2. The function would then be a second order model
of the form
f(xi) = f(xi1, xi2, . . . , xip) = β0 +
p∑
j=1
βjxij +
p∑
j=1
βjjx
2
ij +
p−1∑
j=1
p∑
k<j
βjkxijxik. (4.18)
4.2.2 Experimental Design
Second order models that include all two factor interaction have 1 + 2p+ p(p− 1)/2 param-
eters. To estimate the β parameters the experimental design has to have 1 + 2p + p(p − 1)/2
distinct design points as well as having at least 3 levels of each design variable for the estima-
tion of the pure quadratic terms. Along with this, r ≥ 2 replicates are needed at each design
point to estimate the variation. This implies that at least r (1 + 2p+ p(p− 1)/2) runs of the
computer code will be needed to estimate the variation at each design point as well as the
parameters of the response model.
A Latin Hypercube Sampling design is a method of selecting input variables for computer
experiments such that all sections of the design space are represented (McKay et al. (1979)).
The space filling property of the Latin Hypercube design is appealing in this application when
the desire is the estimation of input parameters since the location in the parameter space is
unknown. The Latin Hypercube design ensures that points are marginally spaced evenly over
values of each input variable (Santner et al. (2003)). Let x·1,x·2, . . . ,x·p be the p column vectors
of design matrix X, where x·j represents the values of the jth input variable for the design
matrix. Without loss of generality, assume each input xij for i = 1, . . . , n and j = 1, . . . , p
exists on the unit interval [0, 1]. For each column vector, the interval is partitioned into n
evenly spaced regions, [0, 1n), . . . , [
n−1
n , 1]. One value is uniformly sampled from each region at
random. The column vector x·j is made up of these n values such that the value sampled from
the first, second, and nth regions are x1j , x2j , and xnj . Let x
∗
·j be a random permutation of x·j
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then construct the design matrix with the p column vectors x·j for j = 1, . . . , p. The result is
a Latin Hypercube design of size n where each row and column are independent.
4.2.3 Fitting Second Order Polynomial Model
The method of least squares estimation is commonly used in the estimation of regression
coefficient in regression models. This method chooses β’s such that Q, the sum of squared
errors, is minimized.
Q =
n∑
i=1
(yi − f(xi))2 (4.19)
The values that minimize Q in Equation (4.19) are the least squares estimators, βˆ, of the
regression coefficients in Equation (4.18).
A =

1 x11 . . . x1p x11x12 . . . x1p−1x1p x211 . . . x21p
1 x21 . . . x2p x21x22 . . . x2p−1x2p x221 . . . x22p
...
...
...
...
...
...
...
...
...
...
1 xn1 . . . xnp xn1xn2 . . . xnp−1xnp x2n1 . . . x2np

(4.20)
y =

y1
y2
...
yn

(4.21)
In matrix notation, the least squares solution, βˆ, is obtained by βˆ = (A′A)−1Ay. The least
squares estimators have the property of being unbiased estimators.
4.3 Emulation of Stochastic ABM of In Vitro EIAV Infection
Consider the ABM described in Chapter 3 for simulating the in vitro infection of EIAV.
This ABM simulates the in vitro competition experiments between two variants of EIAV. In
the model, susceptible cells are randomly seeded in a monolayer inside of discretized well space.
The cells are then infected with two EIAV variants. Cell are able to divide and become infected
through cell free infection or through cell associated spread. The input parameters govern the
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initialization and the rates at which events in the model occur. The stochastic nature of the
ABM lies within the execution of events according to times that are randomly generated from
distributions that depend on the rate parameters in Table 4.1. Each cell that is capable of
performing an event maintains an event timer. This event timer is initialized with an event
time that is exponentially distributed with the appropriate rate parameter. Cells in the well
space also divide at times that are randomly drawn from an exponential distribution with a fixed
mean doubling rate that is equal for both susceptible and infected cells. Observations from the
model are recorded at specified time points. At each time point the number of susceptible cells,
PND1 infected cells, and PND5 infected cells recorded. We describe the usage of a Gaussian
process model to emulate the log PND1 infected cell count at 17 hours post infection.
4.3.1 Gaussian process model
A Latin Hypercube design of size n = 150 was constructed for input parameters over
the ranges included in Table 4.1. For input vector xi in the design matrix, the computer
model was used to generate r = 40 replicate observations of log PND1 infected cell count,
zi = (zi1, zi2, . . . , zir), where i = 1, 2, . . . , n. A Gaussian process model with constant mean
µ and a squared exponential correlation function is fit to the vector of mean computer model
output z¯. The Gaussian process was fit using R package mlegp (Dancik (2008)). The maximum
likelihood estimates of the parameters are included in Table 4.2. The sample mean of
the computer model observations are then modeled as conditionally normal with mean vector
µ(X) and variance matrix σ2GPK(·, ·) + ΣN . The predictive distribution of z¯ at an unobserved
computer model input vector xnew is normal with mean and variance
E[z¯ | xnew] = µ(xnew) + σ2GP k(xnew)V −1(Z¯− µ(X)) (4.22)
V AR[z¯ | xnew] = σ2GP + τ2xnew − σ4GPk(xnew)′V −1k(xnew). (4.23)
The term τ2xnew = sˆ
2
newr
−1 = exp(f(xnew))r−1 is the predicted additional variance due to
stochasticity where function f(·) is the second order response surface model defined in Equa-
tion (4.18). Vector k(xnew) is the correlation between xnew and all of the other inputs used to fit
the Gaussian process model such that the jth element isK(xnew,xj) = exp
{∑p
i=1 di(x
new
i − xij)2
}
.
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4.3.1.1 Polynomial Model of Variation
The full second order polynomial with interactions, Equation 4.17, was fit using least squares
to the log sample variances. An analysis of variance is given in Table 4.3 with the partial F-test
for testing the significance of first, second, and interaction regression terms. Each set of terms
seem to be significant indicating that at least one of each regression coefficient in each group
is not equal to zero. Figure 4.5 shows a plot of the residuals versus fitted values of the
full second order polynomial model. There appears to be a few large outliers, but there is
no gross violation of the modeling assumptions to suggest that there is a problem of constant
error variation. Figure 4.6 is a Normal Quantile plot of the residuals. Apart from the possible
outliers, there does not seem to me any major deviation from the assumption of normality of
the errors.
4.3.2 Model Validation
A model’s predictive ability can be validated by collecting new independent data and com-
paring model predictions to the new observations, comparing model results with theoretical
expectations, or by initially dividing the data with the intentions to use a portion for model
fitting and the other for validation. The best method for validating a model is through the
collection of new data (Kutner et al. (2005)). However, situations dictate which validation
seems most feasible or appropriate. For instance, in some applications collecting new indepen-
dent data may be difficult or impossible because there may be obstacles in creating the exact
experimental conditions in which the first observations were made. In cases where this is the
situation, a sufficient amount of data could be collected initially so that the data could be sep-
arated for independent model fitting and validation. Theoretical results may not be available.
This can be overcome through the use of simulation, however, often is the case that there is
not enough information about the process to provide the basis for such a simulation.
The response we are modeling is observed from a computer experiment which makes the
recreation of the exact experimental conditions trivial. The predictive ability of the polyno-
mial model can be assessed by observing the model’s ability to predict new random outcomes
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Table 4.1 Input to ABM computer model for in vitro competition experiments of EIAV
Parameter Range Description
x1 (1,400) Rate of Cell Free Infection of PND1
x2 (0,20) Rate of Cell Free Infection of PND5
x3 (0,60) Rate of Cell Associated Spread
x4 (1,60) Initial FFU/µl
x5 (1,60) Initial FFU/µl
Table 4.2 Maximum Likelihood estimates of Gaussian Process model for modeling log PND1
infected cell counts at 17 hours post infection.
Parameter Estimate
µ 6.730
σ2GP 2.300
b1 2.845e-6
b2 1.551e-6
b3 3.038e-3
b4 6.106e-3
b5 3.763e-7
Table 4.3 Analysis of variance for full second order polynomial model of log sample variance
of observed log PND1 counts at 17 hours
Source df SS MS F P-Value
First-Order Terms 5 287.56 57.512 213.389 < 0.0001
Interaction Terms 10 6.008 0.601 2.229 0.02
Second-Order Terms 5 42.994 8.599 31.905 < 0.0001
Residuals 129 34.768 0.270
Total 149 371.330
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Figure 4.5 Residual plot from full second order polynomial regression model of stochastic
variation in observed log PND1 infected cell count
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Figure 4.6 Normal Quantile plot of residuals from full second order polynomial regression
model of stochastic variation in observed log PND1 infected cell count
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independent of the data used to fit the model. To measure the predictive ability of the model
we consider using the mean squared prediction error (MSPR). The MSPR is commonly used
to measure predictive accuracy of models (Wallach and Goffinet (1989)).
MSPR =
∑n∗
i=1
(
log s2i − log sˆ2i
)2
n∗
(4.24)
The MSPR in relation to the MSE is an indicator of how well the polynomial model is able to
predict.
Another Latin Hypercube design of size n∗ = 150 for the parameters in Table 4.1 is con-
structed. The computer model is used independently of any runs used to build the regression
model for the stochastic variation. Let X∗ be the design matrix composed of this Latin Hy-
percube design of size n∗. To be able to calculate the stochastic variation, r∗ = 10 replicate
runs of the model are executed for each of the n∗ input vectors in X∗. Observations of the log
variation from the computer model with design X∗ compared with predictions from the model
in Equation (4.17) resulted in a MSPR of 0.542, which is not very distant from the MSE.
The ultimate goal is to make predictions of the computer model at untried input values. To
assess the ability of the Gaussian process model to emulate the ABM we consider comparing
data simulated from the ABM at parameter vector xv = (21.271, 2.716, 29.338, 2.698, 2.234).
The values in xv are the estimates of the posterior mean of each marginal posterior for
x1, x2, x3, x4, and x5 respectively. The ABM was used to generate 100 replicates of log PND1
infected cells at t = 17 hours using the posterior mean of the input parameters. Figure 4.7 is
the histogram of the 100 replicate observations of the computer model with input vector xv.
The Gaussian process predictive distribution is overlaid. The observations from the computer
model had mean 3.481 and variance 0.739. The Gaussian process predictive distribution has
mean 3.217 and variance 0.316. This predictive distribution is a very reasonable fit to the
computer model output with parameter vector xv. To understand the context of this predic-
tive distribution fit, consider the spread in the variances and mean output from the computer
model generated from the Latin Hypercube sample of size 150 in Section 4.3.1. Boxplots of the
sample means and variances from the Latin Hypercube design are shown in Figure 4.8. It is
clear that the predictive distribution from the Gaussian Process is specific as opposed to being
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vague or sensitive to the distribution of observations given the design matrix used.
4.4 Discussion
In this chapter we reviewed methods that have been proposed to model the output of
stochastic computer models. These methods extend the ideas and concepts used to emulate
the output from deterministic computer models. We proposed to model output generated by
a stochastic computer model by independently estimating the stochastic variation with a re-
gression model that is a function of the input variables of the computer model. A stationary
Gaussian Process is fit to the mean of replicate observations of the computer model. The
variance across replications is used as estimates of the stochastic variation and used to fit
the regression model. A stochastic agent based model of in vitro EIAV infection was used to
demonstrate the emulation procedure. This is a stochastic computer model that models infec-
tion experiments that involve cell-virus interactions in a discrete space over time. The Gaussian
process emulation model using a polynomial regression model for the stochastic variance is able
to adequately simulate the output from the computer model.
The usage of a polynomial model regression model to model the stochastic variance provides
a way to extend Gaussian process models to better emulate stochastic output. In this fashion,
we are able to provide estimates of this additive variance at untried input variables. Henderson
et al. (2009) propose instead to model the additional variance with an independent Gaussian
process model which also allows for independent prediction of the additional stochastic variance.
However, the task of fitting two Gaussian process models is significantly more computationally
complex than fitting the regression model. Regression models also provide simple framework
for variable selection and model diagnostics.
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Figure 4.7 Histogram of 100 replicate computer model observations with Gaussian Process
predictive distribution
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design used to fit the Gaussian Process predictive distribution
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CHAPTER 5. Conclusion and Future Work
5.1 Summary
The statistical models of the EIAV infection assays were useful in providing a way to esti-
mate parameters describing the experiments. In Chapter 2, a nonlinear mixed effects differential
equation model was used to describe an in vivo competition infection assay of EIAV in SCID
foals. The model provided an adequate fit to the data. Results revealed that on an individual
foal level there was a significant difference in the rates of infection among the two competing
variants. Chapter 3 detailed the development of a stochastic agent based model of in vitro
EIAV competition experiments. This model was able to distinguish between cell associated
and cell free spread of virus. Chapter 4 describes the usage of polynomial regression models to
estimate the stochastic variance in the output of stochastic computer models. The polynomial
models were used as an extension to Gaussian process models which were used to emulate
the stochastic agent based model to provide a computationally efficient way to estimate the
parameters of the computer model.
5.2 Future Work
Extensions and further developments can be made to the stochastic agent based model.
Currently, the model has a very simplistic implementation of cell free spread in which during a
cell free infection event, any susceptible cell could become infected. This ignores the fact that
susceptible cells closer to the infected cell would more likely come into contact with viruses
budding from the infected cell. Also, the model does not directly model viruses as agents in
the model. Including viruses in the model would increase the complexity of the model, but this
would lead to an increase in the flexibility of the model. A sensitivity analysis of the modeling
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choices in the computer model would be valuable to assess the effects of the assumptions of the
model. Such modeling choices include, the nearest 8 neighborhood structure that cell division
and cell associated spread are confined to, the specification of a 100 × 100 grid well space, and
the a priori estimation of the rate of cell division.
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